Statin (Indonesian Wikipedia)

Reamy BV, Stephens MB (Juli 2007). "The grapefruit-drug interaction debate: role of statins". American Family Physician. 76 (2): 190, 192, author reply 192. PMID 17695563. Diarsipkan dari versi aslinya tanggal 10 November 2018. Diakses tanggal 29 April 2012.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

acc.org (Global: low place; Indonesian: low place)

"Assessing Severity of Statin Side Effects: Fact Versus Fiction". American College of Cardiology. Diakses tanggal 11 November 2023.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

adsabs.harvard.edu (Global: 14^th place; Indonesian: 19^th place)

ui.adsabs.harvard.edu

Endo A (2010). "A historical perspective on the discovery of statins". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (5): 484–493. Bibcode:2010PJAB...86..484E. doi:10.2183/pjab.86.484. PMC 3108295. PMID 20467214.
Rochlani Y, Kattoor AJ, Pothineni NV, Palagiri RD, Romeo F, Mehta JL (Oktober 2017). "Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention". The American Journal of Cardiology (Review). 120 (7): 1122–1128. Bibcode:1981AmJC...48..728H. doi:10.1016/j.amjcard.2017.06.054. PMID 28797470.
Bansal D, Undela K, D'Cruz S, Schifano F (2012). "Statin use and risk of prostate cancer: a meta-analysis of observational studies". PLOS ONE. 7 (10) e46691. Bibcode:2012PLoSO...746691B. doi:10.1371/journal.pone.0046691. PMC 3462187. PMID 23049713.
Tan M, Song X, Zhang G, Peng A, Li X, Li M, et al. (2013). "Statins and the risk of lung cancer: a meta-analysis". PLOS ONE. 8 (2) e57349. Bibcode:2013PLoSO...857349T. doi:10.1371/journal.pone.0057349. PMC 3585354. PMID 23468972.
Lin TK, Chou P, Lin CH, Hung YJ, Jong GP (2018). "Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study". PLOS ONE. 13 (5) e0196713. Bibcode:2018PLoSO..1396713L. doi:10.1371/journal.pone.0196713. PMC 5933736. PMID 29723231.
Istvan ES, Deisenhofer J (Mei 2001). "Structural mechanism for statin inhibition of HMG-CoA reductase". Science. 292 (5519): 1160–1164. Bibcode:2001Sci...292.1160I. doi:10.1126/science.1059344. PMID 11349148. S2CID 37686043.
Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstein JL, Brown MS (November 1986). "Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits". Proceedings of the National Academy of Sciences of the United States of America. 83 (21): 8370–8374. Bibcode:1986PNAS...83.8370M. doi:10.1073/pnas.83.21.8370. PMC 386930. PMID 3464957.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

agenziafarmaco.gov.it (Global: low place; Indonesian: low place)

farmaci.agenziafarmaco.gov.it

"Triveram" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.
"Triveram (2)" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 11 Agustus 2020. Diakses tanggal 7 Februari 2020.
"Cholecomb" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 26 Agustus 2021. Diakses tanggal 7 Februari 2020.
"Cholecomb (2)" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.
"Rosumibe" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.
"Rosumibe (2)" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.

ahajournals.org (Global: 4,716^th place; Indonesian: 3,949^th place)

Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (2019). "Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–e81. doi:10.1161/ATV.0000000000000073. ISSN 1079-5642. PMID 30580575. Diarsipkan dari versi aslinya tanggal 28 Mei 2024. Diakses tanggal 14 Mei 2024.

archive-it.org (Global: 1,292^nd place; Indonesian: 892^nd place)

wayback.archive-it.org

"ANDA Approval Reports - First-Time Generics - December 2001". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"ANDA Approval Reports - First-Time Generics - April 2006". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"ANDA Approval Reports - First-Time Generics - June 2006". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"ANDA Approval Reports - First-Time Generic Drug Approvals - November 2011". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"ANDA Approval Reports - First-Time Generic Drug Approvals - April 2012". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.

archive.org (Global: 6^th place; Indonesian: 3^rd place)

Scandinaviansimvastatinsurvival (November 1994). "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)". Lancet. 344 (8934): 1383–1389. doi:10.1016/S0140-6736(94)90566-5. PMID 7968073. S2CID 5965882.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. (April 2015). "Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials". The Lancet. 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID 25579834. S2CID 35330627.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, et al. (November 2016). "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 316 (19): 1997–2007. doi:10.1001/jama.2016.15450. PMID 27838723. S2CID 205075217.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Taylor FC, Huffman M, Ebrahim S (Desember 2013). "Statin therapy for primary prevention of cardiovascular disease". JAMA. 310 (22): 2451–2452. doi:10.1001/jama.2013.281348. PMID 24276813.
Nissen SE (Desember 2014). "Prevention guidelines: bad process, bad outcome". JAMA Internal Medicine. 174 (12): 1972–1973. doi:10.1001/jamainternmed.2014.3278. PMID 25285604.
Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V (September 2013). "The safety of statins in children". Acta Paediatrica. 102 (9): 857–862. doi:10.1111/apa.12280. PMID 23631461. S2CID 22846175.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Omar MA, Wilson JP (Februari 2002). "FDA adverse event reports on statin-associated rhabdomyolysis". The Annals of Pharmacotherapy. 36 (2): 288–295. doi:10.1345/aph.1A289. PMID 11847951. S2CID 43757439.
Swiger KJ, Manalac RJ, Blumenthal RS, Blaha MJ, Martin SS (November 2013). "Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects". Mayo Clinic Proceedings. 88 (11): 1213–1221. doi:10.1016/j.mayocp.2013.07.013. PMID 24095248.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, et al. (November 2013). "Statins and cognitive function: a systematic review". Annals of Internal Medicine. 159 (10): 688–697. doi:10.7326/0003-4819-159-10-201311190-00007. PMID 24247674. S2CID 207536770.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
McDonagh J (Desember 2014). "Statin-related cognitive impairment in the real world: you'll live longer, but you might not like it". JAMA Internal Medicine. 174 (12): 1889. doi:10.1001/jamainternmed.2014.5376. PMID 25347692.
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. (Februari 2010). "Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials". Lancet. 375 (9716): 735–742. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. S2CID 11544414.
Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (Januari 2006). "Statins and cancer risk: a meta-analysis". JAMA. 295 (1): 74–80. doi:10.1001/jama.295.1.74. PMID 16391219.
Istvan ES, Deisenhofer J (Mei 2001). "Structural mechanism for statin inhibition of HMG-CoA reductase". Science. 292 (5519): 1160–1164. Bibcode:2001Sci...292.1160I. doi:10.1126/science.1059344. PMID 11349148. S2CID 37686043.
Cilla DD, Gibson DM, Whitfield LR, Sedman AJ (Juli 1996). "Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening". Journal of Clinical Pharmacology. 36 (7): 604–609. doi:10.1002/j.1552-4604.1996.tb04224.x. PMID 8844442. S2CID 13586550.
Ridker PM, Glynn RJ (November 2010). "The JUPITER Trial: responding to the critics". The American Journal of Cardiology. 106 (9): 1351–1356. doi:10.1016/j.amjcard.2010.08.025. PMID 21029837.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM (19 Januari 2012). "Generic Atorvastatin and Health Care Costs". New England Journal of Medicine. 366 (3): 201–204. doi:10.1056/NEJMp1113112. ISSN 0028-4793. PMC 3319770. PMID 22149736.
Khurana V, Bejjanki HR, Caldito G, Owens MW (Mei 2007). "Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans". Chest. 131 (5): 1282–1288. doi:10.1378/chest.06-0931. PMID 17494779.

aspetjournals.org (Global: 8,671^st place; Indonesian: 7,247^th place)

dmd.aspetjournals.org

Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, et al. (Maret 1997). "Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved". Drug Metabolism and Disposition. 25 (3): 321–331. PMID 9172950.
Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, et al. (Februari 1999). "Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver". Drug Metabolism and Disposition. 27 (2): 173–179. doi:10.1016/S0090-9556(24)15273-7. PMID 9929499. Diarsipkan dari asli tanggal 26 Agustus 2021. Diakses tanggal 8 November 2018.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

cardiobrief.org (Global: low place; Indonesian: low place)

Husten L (24 Juli 2017). "Nissen Calls Statin Denialism A Deadly Internet-Driven Cult". CardioBrief. Diarsipkan dari versi aslinya tanggal 19 Desember 2017. Diakses tanggal 19 Desember 2017.

cnn.com (Global: 36^th place; Indonesian: 61^st place)

money.cnn.com

Simons J (Januari 2003). "The $10 billion pill". Fortune. Vol. 147, no. 1. hlm. 58–62, 66, 68. PMID 12602122.

consumerreports.org (Global: 6,864^th place; Indonesian: 5,636^th place)

table adapted from the following source, but check individual references for technical explanations
- Consumer Reports, Drug Effectiveness Review Project (Maret 2013), "Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price" (PDF), Best Buy Drugs, Consumer Reports, hlm. 9, diarsipkan (PDF) dari versi aslinya tanggal 4 Februari 2017, diakses tanggal 27 Maret 2013

cvriskcalculator.com (Global: low place; Indonesian: low place)

"ACC/AHA ASCVD Risk Calculator". www.cvriskcalculator.com. Diarsipkan dari asli tanggal 9 Maret 2019. Diakses tanggal 8 Maret 2019.

doi.org (Global: 2^nd place; Indonesian: 2^nd place)

Alenghat FJ, Davis AM (Februari 2019). "Management of Blood Cholesterol". JAMA. 321 (8): 800–801. doi:10.1001/jama.2019.0015. PMC 6679800. PMID 30715135.
Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. (Januari 2013). "Statins for the primary prevention of cardiovascular disease". The Cochrane Database of Systematic Reviews. 2013 (1) CD004816. doi:10.1002/14651858.CD004816.pub5. PMC 6481400. PMID 23440795.
Naci H, Brugts J, Ades T (Juli 2013). "Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials". Circulation: Cardiovascular Quality and Outcomes. 6 (4): 390–399. doi:10.1161/CIRCOUTCOMES.111.000071. PMID 23838105. S2CID 18340552.
Abd TT, Jacobson TA (Mei 2011). "Statin-induced myopathy: a review and update". Expert Opinion on Drug Safety. 10 (3): 373–387. doi:10.1517/14740338.2011.540568. PMID 21342078. S2CID 207487287.
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. (Desember 2007). "Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths". The Lancet. 370 (9602): 1829–1839. doi:10.1016/S0140-6736(07)61778-4. PMID 18061058. S2CID 54293528.
Maningat P, Gordon BR, Breslow JL (Januari 2013). "How do we improve patient compliance and adherence to long-term statin therapy?". Current Atherosclerosis Reports. 15 (1): 291. doi:10.1007/s11883-012-0291-7. PMC 3534845. PMID 23225173.
Tarn D, Pletcher M, Tosqui R (Juni 2021). "Primary nonadherence to statin medications: Survey of patient perspectives". Preventive Medicine Reports. 22 101357. doi:10.1016/j.pmedr.2021.101357. PMC 8020471. PMID 33842201.
Goldstein JL, Brown MS (Maret 2015). "A century of cholesterol and coronaries: from plaques to genes to statins". Cell. 161 (1): 161–172. doi:10.1016/j.cell.2015.01.036. PMC 4525717. PMID 25815993.
Endo A (2010). "A historical perspective on the discovery of statins". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (5): 484–493. Bibcode:2010PJAB...86..484E. doi:10.2183/pjab.86.484. PMC 3108295. PMID 20467214.
Endo A (November 1992). "The discovery and development of HMG-CoA reductase inhibitors". Journal of Lipid Research. 33 (11): 1569–1582. doi:10.1016/S0022-2275(20)41379-3. PMID 1464741.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brown AG, Smale TC, King TJ, Hasenkamp R, Thompson RH (1976). "Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum". Journal of the Chemical Society, Perkin Transactions 1 (11): 1165–1170. doi:10.1039/P19760001165. PMID 945291.
Ko HH, Lareu RR, Dix BR, Hughes JD (24 Oktober 2017). "Statins: antimicrobial resistance breakers or makers?". PeerJ. 5 e3952. doi:10.7717/peerj.3952. ISSN 2167-8359. PMC 5659212. PMID 29085751.
Gesto DS, Pereira CM, Cerqueira NM, Sousa SF (26 Agustus 2020). "An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia". Molecules. 25 (17): 3891. doi:10.3390/molecules25173891. ISSN 1420-3049. PMC 7503714. PMID 32859023.
Scandinaviansimvastatinsurvival (November 1994). "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)". Lancet. 344 (8934): 1383–1389. doi:10.1016/S0140-6736(94)90566-5. PMID 7968073. S2CID 5965882.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. (November 2016). "Interpretation of the evidence for the efficacy and safety of statin therapy". Lancet (Submitted manuscript). 388 (10059): 2532–2561. doi:10.1016/S0140-6736(16)31357-5. hdl:10044/1/43661. PMID 27616593. S2CID 4641278.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Tunnicliffe DJ, Palmer SC, Cashmore BA, Saglimbene VM, Krishnasamy R, Lambert K, et al. (29 November 2023). "HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis". The Cochrane Database of Systematic Reviews. 11 (11) CD007784. doi:10.1002/14651858.CD007784.pub3. ISSN 1469-493X. PMC 10685396. PMID 38018702.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Byrne P, Demasi M, Jones M, Smith SM, O'Brien KK, DuBroff R (Mei 2022). "Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 182 (5): 474–481. doi:10.1001/jamainternmed.2022.0134. PMC 8922205. PMID 35285850.
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. (April 2015). "Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials". The Lancet. 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID 25579834. S2CID 35330627.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cangemi R, Romiti GF, Campolongo G, Ruscio E, Sciomer S, Gianfrilli D, et al. (Maret 2017). "Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate". Pharmacological Research. 117: 148–155. doi:10.1016/j.phrs.2016.12.027. PMID 28012963. S2CID 32861954.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. (Juni 2019). "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 73 (24): e285–e350. doi:10.1016/j.jacc.2018.11.003. hdl:20.500.12749/1738. PMID 30423393.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, et al. (November 2016). "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 316 (19): 1997–2007. doi:10.1001/jama.2016.15450. PMID 27838723. S2CID 205075217.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, et al. (Februari 2019). "Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials". Lancet. 393 (10170): 407–415. doi:10.1016/S0140-6736(18)31942-1. PMC 6429627. PMID 30712900.
Taylor FC, Huffman M, Ebrahim S (Desember 2013). "Statin therapy for primary prevention of cardiovascular disease". JAMA. 310 (22): 2451–2452. doi:10.1001/jama.2013.281348. PMID 24276813.
Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, et al. (November 2011). "Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis". CMAJ. 183 (16): E1189–E1202. doi:10.1503/cmaj.101280. PMC 3216447. PMID 21989464.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB (Februari 2012). "Meta-analysis of statin effects in women versus men". Journal of the American College of Cardiology. 59 (6): 572–582. doi:10.1016/j.jacc.2011.09.067. PMID 22300691.
Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (Januari 2010). "Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis". International Journal of Cardiology. 138 (1): 25–31. doi:10.1016/j.ijcard.2008.08.001. PMID 18793814.
Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, et al. (Juni 2010). "Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants". Archives of Internal Medicine. 170 (12): 1024–1031. doi:10.1001/archinternmed.2010.182. PMID 20585067.
Bukkapatnam RN, Gabler NB, Lewis WR (2010). "Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis". Preventive Cardiology. 13 (2): 84–90. doi:10.1111/j.1751-7141.2009.00059.x. PMID 20377811.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. (Juni 2014). "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. 129 (25 Suppl 2): S1-45. doi:10.1161/01.cir.0000437738.63853.7a. PMID 24222016.
Nissen SE (Desember 2014). "Prevention guidelines: bad process, bad outcome". JAMA Internal Medicine. 174 (12): 1972–1973. doi:10.1001/jamainternmed.2014.3278. PMID 25285604.
Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. (Desember 2011). "[ESC/EAS Guidelines for the management of dyslipidaemias]". Revista Espanola de Cardiologia. 64 (12): 1168.e1–1168.e60. doi:10.1016/j.rec.2011.09.015. hdl:2268/205760. PMID 22115524.
Law MR, Wald NJ, Rudnicka AR (Juni 2003). "Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis". BMJ. 326 (7404): 1423–0. doi:10.1136/bmj.326.7404.1423. PMC 162260. PMID 12829554.
Pisaniello AD, Scherer DJ, Kataoka Y, Nicholls SJ (Februari 2015). "Ongoing challenges for pharmacotherapy for dyslipidemia". Expert Opinion on Pharmacotherapy. 16 (3): 347–356. doi:10.1517/14656566.2014.986094. PMID 25476544. S2CID 539314.
Kushner PA, Cobble ME (November 2016). "Hypertriglyceridemia: the importance of identifying patients at risk". Postgraduate Medicine (Review). 128 (8): 848–858. doi:10.1080/00325481.2016.1243005. PMID 27710158. S2CID 45663315.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Khera AV, Plutzky J (Juli 2013). "Management of low levels of high-density lipoprotein-cholesterol". Circulation (Review). 128 (1): 72–78. doi:10.1161/CIRCULATIONAHA.112.000443. PMC 4231714. PMID 23817482.
Mijajlović MD, Pavlović A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, et al. (Januari 2017). "Post-stroke dementia - a comprehensive review". BMC Medicine. 15 (1): 11. doi:10.1186/s12916-017-0779-7. PMC 5241961. PMID 28095900.
de Waal BA, Buise MP, van Zundert AA (Januari 2015). "Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review". British Journal of Anaesthesia. 114 (1): 44–52. doi:10.1093/bja/aeu295. PMID 25186819.
Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F (Februari 2015). "Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery". Journal of Vascular Surgery. 61 (2): 519–532.e1. doi:10.1016/j.jvs.2014.10.021. PMID 25498191.
Sladojevic N, Yu B, Liao JK (Desember 2017). "ROCK as a therapeutic target for ischemic stroke". Expert Review of Neurotherapeutics. 17 (12): 1167–1177. doi:10.1080/14737175.2017.1395700. PMC 6221831. PMID 29057688.
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, et al. (April 2017). "2017 Taiwan lipid guidelines for high risk patients". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 116 (4): 217–248. doi:10.1016/j.jfma.2016.11.013. PMID 28242176.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Sheng X, Murphy MJ, MacDonald TM, Wei L (30 Agustus 2012). "The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population". BMC Public Health. 12 (1): 712. doi:10.1186/1471-2458-12-712. ISSN 1471-2458. PMC 3490740. PMID 22935195.
Zhang X, Xing L, Jia X, Pang X, Xiang Q, Zhao X, et al. (27 April 2020). "Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials". Cardiovascular Therapeutics. 2020 e3987065. doi:10.1155/2020/3987065. ISSN 1755-5914. PMC 7201823. PMID 32411300.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Adams SP, Tsang M, Wright JM (Maret 2015). "Lipid-lowering efficacy of atorvastatin". The Cochrane Database of Systematic Reviews. 2015 (3) CD008226. doi:10.1002/14651858.CD008226.pub3. PMC 6464917. PMID 25760954.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, et al. (November 2019). "Statins for children with familial hypercholesterolemia". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD006401.pub5. PMC 6836374. PMID 31696945.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V (September 2013). "The safety of statins in children". Acta Paediatrica. 102 (9): 857–862. doi:10.1111/apa.12280. PMID 23631461. S2CID 22846175.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Braamskamp MJ, Wijburg FA, Wiegman A (April 2012). "Drug therapy of hypercholesterolaemia in children and adolescents". Drugs. 72 (6): 759–772. doi:10.2165/11632810-000000000-00000. PMID 22512364. S2CID 21141894.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Repas TB, Tanner JR (Februari 2014). "Preventing early cardiovascular death in patients with familial hypercholesterolemia". The Journal of the American Osteopathic Association. 114 (2): 99–108. doi:10.7556/jaoa.2014.023. PMID 24481802.
Ramasamy I (Februari 2016). "Update on the molecular biology of dyslipidemias". Clinica Chimica Acta; International Journal of Clinical Chemistry. 454: 143–185. doi:10.1016/j.cca.2015.10.033. PMID 26546829.
Rader DJ, Cohen J, Hobbs HH (Juni 2003). "Monogenic hypercholesterolemia: new insights in pathogenesis and treatment". The Journal of Clinical Investigation. 111 (12): 1795–1803. doi:10.1172/JCI18925. PMC 161432. PMID 12813012.
Marais AD, Blom DJ, Firth JC (Januari 2002). "Statins in homozygous familial hypercholesterolemia". Current Atherosclerosis Reports. 4 (1): 19–25. doi:10.1007/s11883-002-0058-7. PMID 11772418. S2CID 8075552.
Liu YH, Liu Y, Duan CY, Tan N, Chen JY, Zhou YL, et al. (Maret 2015). "Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials". Journal of Cardiovascular Pharmacology and Therapeutics. 20 (2): 181–192. doi:10.1177/1074248414549462. PMID 25193735. S2CID 28251228.
Asberg A (2003). "Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients". Drugs. 63 (4): 367–378. doi:10.2165/00003495-200363040-00003. PMID 12558459. S2CID 46971444.
Bellosta S, Paoletti R, Corsini A (Juni 2004). "Safety of statins: focus on clinical pharmacokinetics and drug interactions". Circulation. 109 (23 Suppl 1): III50–III57. doi:10.1161/01.CIR.0000131519.15067.1f. hdl:2434/143653. PMID 15198967.
Omar MA, Wilson JP (Februari 2002). "FDA adverse event reports on statin-associated rhabdomyolysis". The Annals of Pharmacotherapy. 36 (2): 288–295. doi:10.1345/aph.1A289. PMID 11847951. S2CID 43757439.
Armitage J (November 2007). "The safety of statins in clinical practice". Lancet. 370 (9601): 1781–1790. doi:10.1016/S0140-6736(07)60716-8. PMID 17559928. S2CID 205948651.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Bellosta S, Corsini A (November 2012). "Statin drug interactions and related adverse reactions". Expert Opinion on Drug Safety. 11 (6): 933–946. doi:10.1517/14740338.2012.712959. PMID 22866966. S2CID 6247572.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brault M, Ray J, Gomez YH, Mantzoros CS, Daskalopoulou SS (Juni 2014). "Statin treatment and new-onset diabetes: a review of proposed mechanisms". Metabolism. 63 (6): 735–745. doi:10.1016/j.metabol.2014.02.014. PMID 24641882.
Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, et al. (5 Mei 2020). "Drug-Induced Peripheral Neuropathy: A Narrative Review". Current Clinical Pharmacology. 15 (1): 38–48. doi:10.2174/1574884714666190121154813. PMC 7365998. PMID 30666914.
Lehrer S, Rheinstein PH (9 Juni 2020). "Statins combined with niacin reduce the risk of peripheral neuropathy". International Journal of Functional Nutrition. 1 (1). doi:10.3892/ijfn.2020.3. PMC 7737454. PMID 33330853.
Golomb BA, Evans MA (2008). "Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism". American Journal of Cardiovascular Drugs. 8 (6): 373–418. doi:10.2165/0129784-200808060-00004. PMC 2849981. PMID 19159124.
Kmietowicz Z (Maret 2014). "New analysis fuels debate on merits of prescribing statins to low risk people". BMJ. 348 g2370. doi:10.1136/bmj.g2370. PMID 24671956. S2CID 46535820.
Wise J (Juni 2014). "Open letter raises concerns about NICE guidance on statins". BMJ. 348 g3937. doi:10.1136/bmj.g3937. PMID 24920699. S2CID 42422361.
Gøtzsche PC (Juni 2014). "Muscular adverse effects are common with statins". BMJ. 348 g3724. doi:10.1136/bmj.g3724. PMID 24920687. S2CID 206902546.
Silva MA, Swanson AC, Gandhi PJ, Tataronis GR (Januari 2006). "Statin-related adverse events: a meta-analysis". Clinical Therapeutics. 28 (1): 26–35. doi:10.1016/j.clinthera.2006.01.005. PMID 16490577.
Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, et al. (2011). "Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference". The Canadian Journal of Cardiology. 27 (5): 635–662. doi:10.1016/j.cjca.2011.05.007. PMID 21963058.
Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (April 2014). "What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice". European Journal of Preventive Cardiology. 21 (4): 464–474. doi:10.1177/2047487314525531. PMID 24623264. S2CID 21064267.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Swiger KJ, Manalac RJ, Blumenthal RS, Blaha MJ, Martin SS (November 2013). "Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects". Mayo Clinic Proceedings. 88 (11): 1213–1221. doi:10.1016/j.mayocp.2013.07.013. PMID 24095248.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Mancini GB, Tashakkor AY, Baker S, Bergeron J, Fitchett D, Frohlich J, et al. (Desember 2013). "Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update". The Canadian Journal of Cardiology. 29 (12): 1553–1568. doi:10.1016/j.cjca.2013.09.023. PMID 24267801.
Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, et al. (November 2013). "Statins and cognitive function: a systematic review". Annals of Internal Medicine. 159 (10): 688–697. doi:10.7326/0003-4819-159-10-201311190-00007. PMID 24247674. S2CID 207536770.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Smith DA (Mei 2014). "ACP Journal Club. Review: statins are not associated with cognitive impairment or dementia in cognitively intact adults". Annals of Internal Medicine. 160 (10): JC11, JC10. doi:10.7326/0003-4819-160-10-201405200-02011. PMID 24842433. S2CID 1990708.
Bitzur R (Agustus 2016). "Remembering Statins: Do Statins Have Adverse Cognitive Effects?". Diabetes Care (Review). 39 (Supplement 2): S253–S259. doi:10.2337/dcS15-3022. PMID 27440840.
O'Brien EC, Greiner MA, Xian Y, Fonarow GC, Olson DM, Schwamm LH, et al. (Oktober 2015). "Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study". Circulation. 132 (15): 1404–1413. doi:10.1161/CIRCULATIONAHA.115.016183. PMID 26246175. S2CID 11252336.
McDonagh J (Desember 2014). "Statin-related cognitive impairment in the real world: you'll live longer, but you might not like it". JAMA Internal Medicine. 174 (12): 1889. doi:10.1001/jamainternmed.2014.5376. PMID 25347692.
Backes JM, Ruisinger JF, Gibson CA, Moriarty PM (Januari–Februari 2017). "Statin-associated muscle symptoms-Managing the highly intolerant". Journal of Clinical Lipidology. 11 (1): 24–33. doi:10.1016/j.jacl.2017.01.006. PMID 28391891.
Yusuf S (September 2016). "Why do people not take life-saving medications? The case of statins". Lancet. 388 (10048): 943–945. doi:10.1016/s0140-6736(16)31532-x. PMID 27598664. S2CID 34832961.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Herrett E, Williamson E, Brack K, Beaumont D, Perkins A, Thayne A, et al. (Februari 2021). "Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials". BMJ. 372: n135. doi:10.1136/bmj.n135. PMC 7903384. PMID 33627334.
Wood FA, Howard JP, Finegold JA, Nowbar AN, Thompson DM, Arnold AD, et al. (November 2020). "N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects". The New England Journal of Medicine. 383 (22): 2182–2184. doi:10.1056/NEJMc2031173. hdl:10044/1/84185. PMID 33196154. S2CID 226971988.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Colloca L, Barsky AJ (Februari 2020). "Placebo and Nocebo Effects". The New England Journal of Medicine. 382 (6): 554–561. doi:10.1056/NEJMra1907805. PMID 32023375. S2CID 211046068.
Nelson AJ, Puri R, Nissen SE (Juni 2020). "Statins in a Distorted Mirror of Media". Current Atherosclerosis Reports. 22 (8): 37. doi:10.1007/s11883-020-00853-9. PMID 32557172. S2CID 219730531.
Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. (November 2010). "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials". Lancet. 376 (9753): 1670–1681. doi:10.1016/S0140-6736(10)61350-5. PMC 2988224. PMID 21067804.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (Februari 2019). "Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–e81. doi:10.1161/ATV.0000000000000073. PMID 30580575.
Mendes P, Robles PG, Mathur S (2014). "Statin-induced rhabdomyolysis: a comprehensive review of case reports". Physiotherapy Canada. Physiotherapie Canada. 66 (2): 124–132. doi:10.3138/ptc.2012-65. PMC 4006404. PMID 24799748.
Potgieter M, Pretorius E, Pepper MS (Maret 2013). "Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation". Nutrition Reviews. 71 (3): 180–188. doi:10.1111/nure.12011. PMID 23452285.
Tan JT, Barry AR (Juni 2017). "Coenzyme Q10 supplementation in the management of statin-associated myalgia". American Journal of Health-System Pharmacy. 74 (11): 786–793. doi:10.2146/ajhp160714. PMID 28546301. S2CID 3825396.
Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, et al. (Agustus 2008). "SLCO1B1 variants and statin-induced myopathy--a genomewide study". The New England Journal of Medicine. 359 (8): 789–799. doi:10.1056/NEJMoa0801936. PMID 18650507.
Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, et al. (Desember 2004). "Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs". JAMA. 292 (21): 2585–2590. doi:10.1001/jama.292.21.2585. PMID 15572716.
Backman JT, Filppula AM, Niemi M, Neuvonen PJ (Januari 2016). "Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions". Pharmacological Reviews (Review). 68 (1): 168–241. doi:10.1124/pr.115.011411. PMID 26721703.
Hanai J, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, et al. (Desember 2007). "The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity". The Journal of Clinical Investigation. 117 (12): 3940–3951. doi:10.1172/JCI32741. PMC 2066198. PMID 17992259.
Teichtahl AJ, Brady SR, Urquhart DM, Wluka AE, Wang Y, Shaw JE, et al. (Februari 2016). "Statins and tendinopathy: a systematic review". The Medical Journal of Australia. 204 (3): 115–21.e1. doi:10.5694/mja15.00806. PMID 26866552. S2CID 4652858.
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. (Februari 2010). "Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials". Lancet. 375 (9716): 735–742. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. S2CID 11544414.
Chou R, Dana T, Blazina I, Daeges M, Jeanne TL (November 2016). "Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force". JAMA (Review). 316 (19): 2008–2024. doi:10.1001/jama.2015.15629. PMID 27838722.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Rochlani Y, Kattoor AJ, Pothineni NV, Palagiri RD, Romeo F, Mehta JL (Oktober 2017). "Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention". The American Journal of Cardiology (Review). 120 (7): 1122–1128. Bibcode:1981AmJC...48..728H. doi:10.1016/j.amjcard.2017.06.054. PMID 28797470.
He Y, Li X, Gasevic D, Brunt E, McLachlan F, Millenson M, et al. (Oktober 2018). "Statins and Multiple Noncardiovascular Outcomes: Umbrella Review of Meta-analyses of Observational Studies and Randomized Controlled Trials". Annals of Internal Medicine. 169 (8): 543–553. doi:10.7326/M18-0808. PMID 30304368. S2CID 52953760.
Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. (Juni 2011). "Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis". JAMA. 305 (24): 2556–2564. doi:10.1001/jama.2011.860. hdl:10044/1/39305. PMID 21693744.
Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, et al. (Januari 2012). "Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative". Archives of Internal Medicine. 172 (2): 144–152. doi:10.1001/archinternmed.2011.625. PMID 22231607.
Carmena R, Betteridge DJ (April 2019). "Diabetogenic Action of Statins: Mechanisms". Current Atherosclerosis Reports. 21 (6): 23. doi:10.1007/s11883-019-0780-z. PMID 31037345. S2CID 140506916.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S (September 2012). "The controversies of statin therapy: weighing the evidence". Journal of the American College of Cardiology. 60 (10): 875–881. doi:10.1016/j.jacc.2012.07.007. PMID 22902202.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Rutishauser J (21 November 2011). "Statins in clinical medicine". Swiss Medical Weekly. 141: w13310. doi:10.4414/smw.2011.13310. PMID 22101921.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH (Juli 2007). "Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials". Journal of the American College of Cardiology. 50 (5): 409–418. doi:10.1016/j.jacc.2007.02.073. PMID 17662392.
Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (Januari 2006). "Statins and cancer risk: a meta-analysis". JAMA. 295 (1): 74–80. doi:10.1001/jama.295.1.74. PMID 16391219.
Alsheikh-Ali AA, Karas RH (Maret 2009). "The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials". Current Atherosclerosis Reports. 11 (2): 100–104. doi:10.1007/s11883-009-0016-8. PMID 19228482. S2CID 42869773.
Singh S, Singh AG, Singh PP, Murad MH, Iyer PG (Juni 2013). "Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis". Clinical Gastroenterology and Hepatology. 11 (6): 620–629. doi:10.1016/j.cgh.2012.12.036. PMC 3660516. PMID 23357487.
Liu Y, Tang W, Wang J, Xie L, Li T, He Y, et al. (Februari 2014). "Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies". Cancer Causes & Control. 25 (2): 237–249. doi:10.1007/s10552-013-0326-6. PMID 24265089. S2CID 17931279.
Wu XD, Zeng K, Xue FQ, Chen JH, Chen YQ (Oktober 2013). "Statins are associated with reduced risk of gastric cancer: a meta-analysis". European Journal of Clinical Pharmacology. 69 (10): 1855–1860. doi:10.1007/s00228-013-1547-z. PMID 23748751. S2CID 16584300.
Singh PP, Singh S (Juli 2013). "Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis". Annals of Oncology. 24 (7): 1721–1730. doi:10.1093/annonc/mdt150. PMID 23599253.
Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, et al. (Mei 2013). "Statins and primary liver cancer: a meta-analysis of observational studies". European Journal of Cancer Prevention. 22 (3): 229–234. doi:10.1097/cej.0b013e328358761a. PMID 23010949. S2CID 37195287.
Zhang Y, Zang T (2013). "Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005-2010". Urologia Internationalis. 90 (3): 259–262. doi:10.1159/000341977. PMID 23052323. S2CID 22078921.
Bansal D, Undela K, D'Cruz S, Schifano F (2012). "Statin use and risk of prostate cancer: a meta-analysis of observational studies". PLOS ONE. 7 (10) e46691. Bibcode:2012PLoSO...746691B. doi:10.1371/journal.pone.0046691. PMC 3462187. PMID 23049713.
Tan M, Song X, Zhang G, Peng A, Li X, Li M, et al. (2013). "Statins and the risk of lung cancer: a meta-analysis". PLOS ONE. 8 (2) e57349. Bibcode:2013PLoSO...857349T. doi:10.1371/journal.pone.0057349. PMC 3585354. PMID 23468972.
Zhang XL, Liu M, Qian J, Zheng JH, Zhang XP, Guo CC, et al. (Maret 2014). "Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials". British Journal of Clinical Pharmacology. 77 (3): 458–465. doi:10.1111/bcp.12210. PMC 3952720. PMID 23879311.
Undela K, Srikanth V, Bansal D (Agustus 2012). "Statin use and risk of breast cancer: a meta-analysis of observational studies". Breast Cancer Research and Treatment. 135 (1): 261–269. doi:10.1007/s10549-012-2154-x. PMID 22806241. S2CID 35249884.
Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, et al. (Juli 2012). "Statin use and risk of pancreatic cancer: a meta-analysis". Cancer Causes & Control. 23 (7): 1099–1111. doi:10.1007/s10552-012-9979-9. PMID 22562222. S2CID 13171692.
Zhang XL, Geng J, Zhang XP, Peng B, Che JP, Yan Y, et al. (April 2013). "Statin use and risk of bladder cancer: a meta-analysis". Cancer Causes & Control. 24 (4): 769–776. doi:10.1007/s10552-013-0159-3. PMID 23361339. S2CID 9030195.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (2019). "Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–e81. doi:10.1161/ATV.0000000000000073. ISSN 1079-5642. PMID 30580575. Diarsipkan dari versi aslinya tanggal 28 Mei 2024. Diakses tanggal 14 Mei 2024.
Kane GC, Lipsky JJ (September 2000). "Drug-grapefruit juice interactions". Mayo Clinic Proceedings. 75 (9): 933–942. doi:10.4065/75.9.933. PMID 10994829.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Lin TK, Chou P, Lin CH, Hung YJ, Jong GP (2018). "Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study". PLOS ONE. 13 (5) e0196713. Bibcode:2018PLoSO..1396713L. doi:10.1371/journal.pone.0196713. PMC 5933736. PMID 29723231.
Wang Z, Li Y, Zhou F, Piao Z, Hao J (Mei 2016). "Effects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-Analysis". Medicine. 95 (22) e3042. doi:10.1097/MD.0000000000003042. PMC 4900696. PMID 27258488.
An T, Hao J, Sun S, Li R, Yang M, Cheng G, et al. (Januari 2017). "Efficacy of statins for osteoporosis: a systematic review and meta-analysis". Osteoporosis International. 28 (1): 47–57. doi:10.1007/s00198-016-3844-8. PMID 27888285. S2CID 4723680.
Larsson BA, Sundh D, Mellström D, Axelsson KF, Nilsson AG, Lorentzon M (Februari 2019). "Association Between Cortical Bone Microstructure and Statin Use in Older Women". The Journal of Clinical Endocrinology and Metabolism. 104 (2): 250–257. doi:10.1210/jc.2018-02054. PMID 30423123.
Leutner M, Matzhold C, Bellach L, Deischinger C, Harreiter J, Thurner S, et al. (Desember 2019). "Diagnosis of osteoporosis in statin-treated patients is dose-dependent". Annals of the Rheumatic Diseases. 78 (12): 1706–1711. doi:10.1136/annrheumdis-2019-215714. PMC 6900255. PMID 31558481.
Istvan ES, Deisenhofer J (Mei 2001). "Structural mechanism for statin inhibition of HMG-CoA reductase". Science. 292 (5519): 1160–1164. Bibcode:2001Sci...292.1160I. doi:10.1126/science.1059344. PMID 11349148. S2CID 37686043.
Miettinen TA (Maret 1982). "Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins". Journal of Lipid Research. 23 (3): 466–473. doi:10.1016/S0022-2275(20)38144-X. PMID 7200504.
Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y (Juli–Agustus 1991). "Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study". Arteriosclerosis and Thrombosis. 11 (4): 816–826. doi:10.1161/01.ATV.11.4.816. PMID 2065035.
Wallace A, Chinn D, Rubin G (Oktober 2003). "Taking simvastatin in the morning compared with in the evening: randomised controlled trial". BMJ. 327 (7418): 788. doi:10.1136/bmj.327.7418.788. PMC 214096. PMID 14525878.
Cilla DD, Gibson DM, Whitfield LR, Sedman AJ (Juli 1996). "Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening". Journal of Clinical Pharmacology. 36 (7): 604–609. doi:10.1002/j.1552-4604.1996.tb04224.x. PMID 8844442. S2CID 13586550.
Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstein JL, Brown MS (November 1986). "Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits". Proceedings of the National Academy of Sciences of the United States of America. 83 (21): 8370–8374. Bibcode:1986PNAS...83.8370M. doi:10.1073/pnas.83.21.8370. PMC 386930. PMID 3464957.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Laufs U, Custodis F, Böhm M (2006). "HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk". Drugs. 66 (2): 145–154. doi:10.2165/00003495-200666020-00002. PMID 16451090. S2CID 46985044.
Greenwood J, Steinman L, Zamvil SS (Mei 2006). "Statin therapy and autoimmune disease: from protein prenylation to immunomodulation". Nature Reviews. Immunology. 6 (5): 358–370. doi:10.1038/nri1839. PMC 3842637. PMID 16639429.
Lahera V, Goicoechea M, de Vinuesa SG, Miana M, de las Heras N, Cachofeiro V, et al. (2007). "Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins". Current Medicinal Chemistry. 14 (2): 243–248. doi:10.2174/092986707779313381. PMID 17266583.
Blum A, Shamburek R (April 2009). "The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis". Atherosclerosis. 203 (2): 325–330. doi:10.1016/j.atherosclerosis.2008.08.022. PMID 18834985.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Porter KE, Turner NA (Juli 2011). "Statins and myocardial remodelling: cell and molecular pathways". Expert Reviews in Molecular Medicine. 13 (e22): e22. doi:10.1017/S1462399411001931. PMID 21718586. S2CID 1975524.
Sawada N, Liao JK (Maret 2014). "Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis". Antioxidants & Redox Signaling. 20 (8): 1251–1267. doi:10.1089/ars.2013.5524. PMC 3934442. PMID 23919640.
Thurnher M, Nussbaumer O, Gruenbacher G (Juli 2012). "Novel aspects of mevalonate pathway inhibitors as antitumor agents". Clinical Cancer Research. 18 (13): 3524–3531. doi:10.1158/1078-0432.CCR-12-0489. PMID 22529099.
Norata GD, Tibolla G, Catapano AL (Oktober 2014). "Statins and skeletal muscles toxicity: from clinical trials to everyday practice". Pharmacological Research. 88: 107–113. doi:10.1016/j.phrs.2014.04.012. PMID 24835295.
Kowluru A (Januari 2008). "Protein prenylation in glucose-induced insulin secretion from the pancreatic islet beta cell: a perspective". Journal of Cellular and Molecular Medicine. 12 (1): 164–173. doi:10.1111/j.1582-4934.2007.00168.x. PMC 3823478. PMID 18053094.
Liao JK, Laufs U (2005). "Pleiotropic effects of statins". Annual Review of Pharmacology and Toxicology. 45: 89–118. doi:10.1146/annurev.pharmtox.45.120403.095748. PMC 2694580. PMID 15822172.
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. (April 2006). "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial". JAMA. 295 (13): 1556–1565. doi:10.1001/jama.295.13.jpc60002. PMID 16533939.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. (November 2008). "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein". The New England Journal of Medicine. 359 (21): 2195–2207. doi:10.1056/NEJMoa0807646. PMID 18997196.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Kones R (Desember 2010). "Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease—a perspective". Drug Design, Development and Therapy. 4: 383–413. doi:10.2147/DDDT.S10812. PMC 3023269. PMID 21267417.
Ferdinand KC (Februari 2011). "Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?". Current Atherosclerosis Reports. 13 (1): 64–72. doi:10.1007/s11883-010-0149-9. PMID 21104458. S2CID 32142669.
Devaraj S, Siegel D, Jialal I (Februari 2011). "Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?". Current Atherosclerosis Reports. 13 (1): 31–42. doi:10.1007/s11883-010-0143-2. PMC 3018293. PMID 21046291.
Ridker PM, Glynn RJ (November 2010). "The JUPITER Trial: responding to the critics". The American Journal of Cardiology. 106 (9): 1351–1356. doi:10.1016/j.amjcard.2010.08.025. PMID 21029837.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Vögeli B, Shima S, Erb TJ, Wagner T (Maret 2019). "Crystal structure of archaeal HMG-CoA reductase: insights into structural changes of the C-terminal helix of the class-I enzyme". FEBS Letters. 593 (5): 543–553. doi:10.1002/1873-3468.13331. PMID 30702149. S2CID 73412833.
Gottlieb K, Wacher V, Sliman J, Pimentel M (Januari 2016). "Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders". Alimentary Pharmacology & Therapeutics. 43 (2): 197–212. doi:10.1111/apt.13469. PMC 4737270. PMID 26559904.
Lurie-Weinberger MN, Gophna U (Juni 2015). "Archaea in and on the Human Body: Health Implications and Future Directions". PLOS Pathogens. 11 (6) e1004833. doi:10.1371/journal.ppat.1004833. PMC 4466265. PMID 26066650.
McKenney JM, Ganz P, Wiggins BS, Saseen JS (2009). "Statins". Clinical Lipidology. Elsevier. hlm. 253–280. doi:10.1016/b978-141605469-6.50026-3. ISBN 978-1-4160-5469-6. The elimination half-life of the statins varies from 1 to 3 hours for lovastatin, simvastatin, pravastatin, and fluvastatin, to 14 to 19 hours for atorvastatin and rosuvastatin (see Table 22-1). The longer the statin's half-life, the longer the inhibition of reductase and thus a greater reduction in LDL cholesterol. However, the impact of inhibiting cholesterol synthesis persists even with statins that have a relatively short half-life. This is due to their ability to reduce blood levels of lipoproteins, which have a half-life of approximately 2 to 3 days. Because of this, all statins may be dosed once daily. The preferred time of administration is in the evening, just before the peak in cholesterol synthesis.
Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, et al. (Februari 1999). "Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver". Drug Metabolism and Disposition. 27 (2): 173–179. doi:10.1016/S0090-9556(24)15273-7. PMID 9929499. Diarsipkan dari asli tanggal 26 Agustus 2021. Diakses tanggal 8 November 2018.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG (Maret 2003). "Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals". The American Journal of Cardiology. 91 (5A): 11C–17C, discussion 17C–19C. doi:10.1016/S0002-9149(03)00004-3. PMID 12646338.
Baldinelli L, Biselli R, Fattorossi A (Februari 2005). "Influence of ST 789 on murine thymocytes: a flow cytometry study of thymocyte subset distribution and of intracellular free Ca++ increase upon activation. Murine thymocytes and ST 789". Thymus. 19 (2 Suppl 1): S53–S61. doi:10.1111/j.1742-1241.2005.00461.x. PMID 1585420. S2CID 221814440.
Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V (November 2006). "Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials". Chinese Medicine. 1 (1): 4. doi:10.1186/1749-8546-1-4. PMC 1761143. PMID 17302963.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM (19 Januari 2012). "Generic Atorvastatin and Health Care Costs". New England Journal of Medicine. 366 (3): 201–204. doi:10.1056/NEJMp1113112. ISSN 0028-4793. PMC 3319770. PMID 22149736.
Wolozin B, Wang SW, Li NC, Lee A, Lee TA, Kazis LE (Juli 2007). "Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease". BMC Medicine. 5 (1): 20. doi:10.1186/1741-7015-5-20. PMC 1955446. PMID 17640385.
Khurana V, Bejjanki HR, Caldito G, Owens MW (Mei 2007). "Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans". Chest. 131 (5): 1282–1288. doi:10.1378/chest.06-0931. PMID 17494779.
Klein BE, Klein R, Lee KE, Grady LM (Juni 2006). "Statin use and incident nuclear cataract". JAMA. 295 (23): 2752–2758. doi:10.1001/jama.295.23.2752. PMID 16788130.
Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH (April 2008). "Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial". Archives of Internal Medicine. 168 (7): 721–727. doi:10.1001/archinte.168.7.721. PMC 4285458. PMID 18413554.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Drapala A, Sikora M, Ufnal M (September 2014). "Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins". Journal of the Renin-Angiotensin-Aldosterone System. 15 (3): 250–258. doi:10.1177/1470320314531058. PMID 25037529.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Mondul AM, Han M, Humphreys EB, Meinhold CL, Walsh PC, Platz EA (April 2011). "Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery". The Journal of Urology. 185 (4): 1268–1273. doi:10.1016/j.juro.2010.11.089. PMC 3584560. PMID 21334020.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Liu B, Yi Z, Guan X, Zeng YX, Ma F (Juli 2017). "The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis". Breast Cancer Research and Treatment. 164 (1): 1–11. doi:10.1007/s10549-017-4246-0. PMID 28432513. S2CID 3900946.
Batais MA, Khan AR, Bin Abdulhak AA (Agustus 2017). "The Use of Statins and Risk of Community-Acquired Pneumonia". Current Infectious Disease Reports. 19 (8): 26. doi:10.1007/s11908-017-0581-x. PMID 28639080. S2CID 20522253.
Wang J, Xiao Y, Luo M, Luo H (Desember 2011). "Statins for multiple sclerosis". The Cochrane Database of Systematic Reviews. 2011 (12) CD008386. doi:10.1002/14651858.CD008386.pub3. PMC 7175839. PMID 22161428.
Gutlapalli SD, Farhat H, Irfan H, Muthiah K, Pallipamu N, Taheri S, et al. (2022). "The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022". Cureus. 14 (12) e32323. doi:10.7759/cureus.32323. ISSN 2168-8184. PMC 9825119. PMID 36628002.
Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, et al. (1 November 2024). "Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study". Heart (dalam bahasa Inggris). 110 (21): 1277–1285. doi:10.1136/heartjnl-2024-324052. ISSN 1355-6037. PMC 11503164. PMID 39256053.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"Older people who take statins live longer in better health". NIHR Evidence. 2025. doi:10.3310/nihrevidence_65725. Diakses tanggal 22 Januari 2025.

fda.gov (Global: 470^th place; Indonesian: 343^rd place)

fda.gov

"First-Time Generics – December 2001". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Juli 2009. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"ANDA Approval Reports - First-Time Generics - December 2001". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"First-Time Generics – April 2006". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Juli 2009. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"ANDA Approval Reports - First-Time Generics - April 2006". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"First-Time Generics – June 2006". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Juli 2009. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"ANDA Approval Reports - First-Time Generics - June 2006". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"First-Time Generic Drug Approvals – November 2011". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 8 Desember 2011. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"ANDA Approval Reports - First-Time Generic Drug Approvals - November 2011". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"First-Time Generic Drug Approvals – April 2012". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 19 Juli 2012. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"ANDA Approval Reports - First-Time Generic Drug Approvals - April 2012". Food and Drug Administration. Diarsipkan dari asli tanggal 13 Januari 2017. Diakses tanggal 12 Februari 2023.
"ANDA (Generic) Drug Approvals in 2016". U.S. Food and Drug Administration (FDA). 3 November 2018. Diarsipkan dari versi aslinya tanggal 11 Agustus 2020. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"FDA approves first generic Crestor". U.S. Food and Drug Administration (FDA) (Rilis pers). 29 April 2016. Diarsipkan dari asli tanggal 15 Maret 2020. Diakses tanggal 26 April 2020.{{cite press release}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"CDER 2017 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 November 2018. Diarsipkan dari asli tanggal 26 April 2020. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury". U.S. Food and Drug Administration (FDA). 1 Maret 2012. Diarsipkan dari versi aslinya tanggal 18 Maret 2013. Diakses tanggal 3 April 2013.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs". U.S. Food and Drug Administration (FDA). 19 Januari 2016. Diarsipkan dari versi aslinya tanggal 13 Oktober 2019. Diakses tanggal 25 Maret 2018.
"Statins and HIV or Hepatitis C Drugs: Drug Safety Communication – Interaction Increases Risk of Muscle Injury". U.S. Food and Drug Administration (FDA). 1 Maret 2012. Diarsipkan dari asli tanggal 18 Januari 2017. Diakses tanggal 12 Oktober 2019.

accessdata.fda.gov

"Lovastatin: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diakses tanggal 12 Februari 2023.
"Pravastatin: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Februari 2023. Diakses tanggal 12 Februari 2023.
"Simvastatin: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diakses tanggal 12 Februari 2023.
"Atorvastatin: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diarsipkan dari versi aslinya tanggal 12 Februari 2023. Diakses tanggal 12 Februari 2023.

gabionline.net (Global: low place; Indonesian: low place)

"Sandoz launches authorized fluvastatin generic in US". GaBI Online. 31 Oktober 2019. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.

gazzettaufficiale.it (Global: 2,811^th place; Indonesian: low place)

"Riclassificazione del medicinale per uso umano 'Triveram', ai sensi dell'articolo 8, comma 10, della legge 24 dicembre 1993, n. 537. (Determina n. DG/1422/2019). (19A06231)". GU Serie Generale n.238 (dalam bahasa Italia). 10 Oktober 2019. Diarsipkan dari versi aslinya tanggal 10 Agustus 2020. Diakses tanggal 7 Februari 2020.

hdl.handle.net (Global: 66^th place; Indonesian: 122^nd place)

World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. (November 2016). "Interpretation of the evidence for the efficacy and safety of statin therapy". Lancet (Submitted manuscript). 388 (10059): 2532–2561. doi:10.1016/S0140-6736(16)31357-5. hdl:10044/1/43661. PMID 27616593. S2CID 4641278.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. (April 2015). "Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials". The Lancet. 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID 25579834. S2CID 35330627.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. (Juni 2019). "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 73 (24): e285–e350. doi:10.1016/j.jacc.2018.11.003. hdl:20.500.12749/1738. PMID 30423393.
Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. (Desember 2011). "[ESC/EAS Guidelines for the management of dyslipidaemias]". Revista Espanola de Cardiologia. 64 (12): 1168.e1–1168.e60. doi:10.1016/j.rec.2011.09.015. hdl:2268/205760. PMID 22115524.
Bellosta S, Paoletti R, Corsini A (Juni 2004). "Safety of statins: focus on clinical pharmacokinetics and drug interactions". Circulation. 109 (23 Suppl 1): III50–III57. doi:10.1161/01.CIR.0000131519.15067.1f. hdl:2434/143653. PMID 15198967.
Wood FA, Howard JP, Finegold JA, Nowbar AN, Thompson DM, Arnold AD, et al. (November 2020). "N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects". The New England Journal of Medicine. 383 (22): 2182–2184. doi:10.1056/NEJMc2031173. hdl:10044/1/84185. PMID 33196154. S2CID 226971988.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. (Juni 2011). "Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis". JAMA. 305 (24): 2556–2564. doi:10.1001/jama.2011.860. hdl:10044/1/39305. PMID 21693744.

heart.org (Global: low place; Indonesian: 7,540^th place)

watchlearnlive.heart.org

"Cholesterol Drugs". American Heart Association. Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 24 Desember 2019.

mayoclinic.com (Global: 6,290^th place; Indonesian: 4,130^th place)

Katherine Zeratsky, R.D., L.D., Mayo clinic: article on interference between grapefruit and medication Diarsipkan 29 October 2013 di Wayback Machine. Accessed 1 May 2017

mayoclinic.org (Global: 2,191^st place; Indonesian: 1,118^th place)

"Should you be worried about severe muscle pain from statins?". Mayo Clinic. Diarsipkan dari versi aslinya tanggal 15 Mei 2024. Diakses tanggal 30 Oktober 2023.

medpagetoday.com (Global: low place; Indonesian: low place)

"Questions Remain in Cholesterol Research". MedPageToday. 15 Agustus 2014. Diarsipkan dari versi aslinya tanggal 25 Februari 2021. Diakses tanggal 27 April 2015.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

nice.org.uk (Global: 4,081^st place; Indonesian: 3,142^nd place)

National Collaborating Centre for Primary Care (2010). NICE clinical guideline 67: Lipid modification (PDF). London: National Institute for Health and Clinical Excellence. hlm. 38. Diarsipkan dari asli (PDF) tanggal 10 Oktober 2010.
"Cardiovascular disease: risk assessment and reduction, including lipid modification at www.nice.org.uk". 18 Juli 2014. Diarsipkan dari versi aslinya tanggal 12 Juni 2018. Diakses tanggal 1 Mei 2017.
National Institute for Health and Clinical Excellence (Maret 2010) [May 2008]. "Lipid modification – Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease – Quick reference guide" (PDF). Diarsipkan dari asli (PDF) tanggal 8 April 2011. Diakses tanggal 25 Agustus 2010.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

nih.gov (Global: 5^th place; Indonesian: 6^th place)

pubmed.ncbi.nlm.nih.gov

Alenghat FJ, Davis AM (Februari 2019). "Management of Blood Cholesterol". JAMA. 321 (8): 800–801. doi:10.1001/jama.2019.0015. PMC 6679800. PMID 30715135.
National Clinical Guideline Centre (UK) (Juli 2014). Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. National Institute for Health and Clinical Excellence: Guidance. London: National Institute for Health and Care Excellence (UK). PMID 25340243. NICE Clinical Guidelines, No. 181. Diarsipkan dari versi aslinya tanggal 29 Mei 2020. Diakses tanggal 26 April 2020 – via National Library of Medicine.{{cite book}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. (Januari 2013). "Statins for the primary prevention of cardiovascular disease". The Cochrane Database of Systematic Reviews. 2013 (1) CD004816. doi:10.1002/14651858.CD004816.pub5. PMC 6481400. PMID 23440795.
Naci H, Brugts J, Ades T (Juli 2013). "Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials". Circulation: Cardiovascular Quality and Outcomes. 6 (4): 390–399. doi:10.1161/CIRCOUTCOMES.111.000071. PMID 23838105. S2CID 18340552.
Abd TT, Jacobson TA (Mei 2011). "Statin-induced myopathy: a review and update". Expert Opinion on Drug Safety. 10 (3): 373–387. doi:10.1517/14740338.2011.540568. PMID 21342078. S2CID 207487287.
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. (Desember 2007). "Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths". The Lancet. 370 (9602): 1829–1839. doi:10.1016/S0140-6736(07)61778-4. PMID 18061058. S2CID 54293528.
Maningat P, Gordon BR, Breslow JL (Januari 2013). "How do we improve patient compliance and adherence to long-term statin therapy?". Current Atherosclerosis Reports. 15 (1): 291. doi:10.1007/s11883-012-0291-7. PMC 3534845. PMID 23225173.
Tarn D, Pletcher M, Tosqui R (Juni 2021). "Primary nonadherence to statin medications: Survey of patient perspectives". Preventive Medicine Reports. 22 101357. doi:10.1016/j.pmedr.2021.101357. PMC 8020471. PMID 33842201.
Goldstein JL, Brown MS (Maret 2015). "A century of cholesterol and coronaries: from plaques to genes to statins". Cell. 161 (1): 161–172. doi:10.1016/j.cell.2015.01.036. PMC 4525717. PMID 25815993.
Endo A (2010). "A historical perspective on the discovery of statins". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (5): 484–493. Bibcode:2010PJAB...86..484E. doi:10.2183/pjab.86.484. PMC 3108295. PMID 20467214.
Simons J (Januari 2003). "The $10 billion pill". Fortune. Vol. 147, no. 1. hlm. 58–62, 66, 68. PMID 12602122.
Endo A (November 1992). "The discovery and development of HMG-CoA reductase inhibitors". Journal of Lipid Research. 33 (11): 1569–1582. doi:10.1016/S0022-2275(20)41379-3. PMID 1464741.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brown AG, Smale TC, King TJ, Hasenkamp R, Thompson RH (1976). "Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum". Journal of the Chemical Society, Perkin Transactions 1 (11): 1165–1170. doi:10.1039/P19760001165. PMID 945291.
Ko HH, Lareu RR, Dix BR, Hughes JD (24 Oktober 2017). "Statins: antimicrobial resistance breakers or makers?". PeerJ. 5 e3952. doi:10.7717/peerj.3952. ISSN 2167-8359. PMC 5659212. PMID 29085751.
Gesto DS, Pereira CM, Cerqueira NM, Sousa SF (26 Agustus 2020). "An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia". Molecules. 25 (17): 3891. doi:10.3390/molecules25173891. ISSN 1420-3049. PMC 7503714. PMID 32859023.
Scandinaviansimvastatinsurvival (November 1994). "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)". Lancet. 344 (8934): 1383–1389. doi:10.1016/S0140-6736(94)90566-5. PMID 7968073. S2CID 5965882.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. (November 2016). "Interpretation of the evidence for the efficacy and safety of statin therapy". Lancet (Submitted manuscript). 388 (10059): 2532–2561. doi:10.1016/S0140-6736(16)31357-5. hdl:10044/1/43661. PMID 27616593. S2CID 4641278.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Tunnicliffe DJ, Palmer SC, Cashmore BA, Saglimbene VM, Krishnasamy R, Lambert K, et al. (29 November 2023). "HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis". The Cochrane Database of Systematic Reviews. 11 (11) CD007784. doi:10.1002/14651858.CD007784.pub3. ISSN 1469-493X. PMC 10685396. PMID 38018702.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Byrne P, Demasi M, Jones M, Smith SM, O'Brien KK, DuBroff R (Mei 2022). "Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 182 (5): 474–481. doi:10.1001/jamainternmed.2022.0134. PMC 8922205. PMID 35285850.
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. (April 2015). "Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials". The Lancet. 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID 25579834. S2CID 35330627.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cangemi R, Romiti GF, Campolongo G, Ruscio E, Sciomer S, Gianfrilli D, et al. (Maret 2017). "Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate". Pharmacological Research. 117: 148–155. doi:10.1016/j.phrs.2016.12.027. PMID 28012963. S2CID 32861954.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. (Juni 2019). "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 73 (24): e285–e350. doi:10.1016/j.jacc.2018.11.003. hdl:20.500.12749/1738. PMID 30423393.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, et al. (November 2016). "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 316 (19): 1997–2007. doi:10.1001/jama.2016.15450. PMID 27838723. S2CID 205075217.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, et al. (Februari 2019). "Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials". Lancet. 393 (10170): 407–415. doi:10.1016/S0140-6736(18)31942-1. PMC 6429627. PMID 30712900.
Taylor FC, Huffman M, Ebrahim S (Desember 2013). "Statin therapy for primary prevention of cardiovascular disease". JAMA. 310 (22): 2451–2452. doi:10.1001/jama.2013.281348. PMID 24276813.
Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, et al. (November 2011). "Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis". CMAJ. 183 (16): E1189–E1202. doi:10.1503/cmaj.101280. PMC 3216447. PMID 21989464.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB (Februari 2012). "Meta-analysis of statin effects in women versus men". Journal of the American College of Cardiology. 59 (6): 572–582. doi:10.1016/j.jacc.2011.09.067. PMID 22300691.
Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (Januari 2010). "Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis". International Journal of Cardiology. 138 (1): 25–31. doi:10.1016/j.ijcard.2008.08.001. PMID 18793814.
Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, et al. (Juni 2010). "Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants". Archives of Internal Medicine. 170 (12): 1024–1031. doi:10.1001/archinternmed.2010.182. PMID 20585067.
Bukkapatnam RN, Gabler NB, Lewis WR (2010). "Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis". Preventive Cardiology. 13 (2): 84–90. doi:10.1111/j.1751-7141.2009.00059.x. PMID 20377811.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. (Juni 2014). "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. 129 (25 Suppl 2): S1-45. doi:10.1161/01.cir.0000437738.63853.7a. PMID 24222016.
Nissen SE (Desember 2014). "Prevention guidelines: bad process, bad outcome". JAMA Internal Medicine. 174 (12): 1972–1973. doi:10.1001/jamainternmed.2014.3278. PMID 25285604.
Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. (Desember 2011). "[ESC/EAS Guidelines for the management of dyslipidaemias]". Revista Espanola de Cardiologia. 64 (12): 1168.e1–1168.e60. doi:10.1016/j.rec.2011.09.015. hdl:2268/205760. PMID 22115524.
Law MR, Wald NJ, Rudnicka AR (Juni 2003). "Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis". BMJ. 326 (7404): 1423–0. doi:10.1136/bmj.326.7404.1423. PMC 162260. PMID 12829554.
Pisaniello AD, Scherer DJ, Kataoka Y, Nicholls SJ (Februari 2015). "Ongoing challenges for pharmacotherapy for dyslipidemia". Expert Opinion on Pharmacotherapy. 16 (3): 347–356. doi:10.1517/14656566.2014.986094. PMID 25476544. S2CID 539314.
Kushner PA, Cobble ME (November 2016). "Hypertriglyceridemia: the importance of identifying patients at risk". Postgraduate Medicine (Review). 128 (8): 848–858. doi:10.1080/00325481.2016.1243005. PMID 27710158. S2CID 45663315.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Khera AV, Plutzky J (Juli 2013). "Management of low levels of high-density lipoprotein-cholesterol". Circulation (Review). 128 (1): 72–78. doi:10.1161/CIRCULATIONAHA.112.000443. PMC 4231714. PMID 23817482.
Mijajlović MD, Pavlović A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, et al. (Januari 2017). "Post-stroke dementia - a comprehensive review". BMC Medicine. 15 (1): 11. doi:10.1186/s12916-017-0779-7. PMC 5241961. PMID 28095900.
de Waal BA, Buise MP, van Zundert AA (Januari 2015). "Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review". British Journal of Anaesthesia. 114 (1): 44–52. doi:10.1093/bja/aeu295. PMID 25186819.
Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F (Februari 2015). "Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery". Journal of Vascular Surgery. 61 (2): 519–532.e1. doi:10.1016/j.jvs.2014.10.021. PMID 25498191.
Sladojevic N, Yu B, Liao JK (Desember 2017). "ROCK as a therapeutic target for ischemic stroke". Expert Review of Neurotherapeutics. 17 (12): 1167–1177. doi:10.1080/14737175.2017.1395700. PMC 6221831. PMID 29057688.
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, et al. (April 2017). "2017 Taiwan lipid guidelines for high risk patients". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 116 (4): 217–248. doi:10.1016/j.jfma.2016.11.013. PMID 28242176.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Sheng X, Murphy MJ, MacDonald TM, Wei L (30 Agustus 2012). "The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population". BMC Public Health. 12 (1): 712. doi:10.1186/1471-2458-12-712. ISSN 1471-2458. PMC 3490740. PMID 22935195.
Bansal AB, Cassagnol M (2023), "HMG-CoA Reductase Inhibitors", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31194369, diakses tanggal 11 November 2023{{citation}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Zhang X, Xing L, Jia X, Pang X, Xiang Q, Zhao X, et al. (27 April 2020). "Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials". Cardiovascular Therapeutics. 2020 e3987065. doi:10.1155/2020/3987065. ISSN 1755-5914. PMC 7201823. PMID 32411300.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Adams SP, Tsang M, Wright JM (Maret 2015). "Lipid-lowering efficacy of atorvastatin". The Cochrane Database of Systematic Reviews. 2015 (3) CD008226. doi:10.1002/14651858.CD008226.pub3. PMC 6464917. PMID 25760954.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, et al. (November 2019). "Statins for children with familial hypercholesterolemia". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD006401.pub5. PMC 6836374. PMID 31696945.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V (September 2013). "The safety of statins in children". Acta Paediatrica. 102 (9): 857–862. doi:10.1111/apa.12280. PMID 23631461. S2CID 22846175.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Braamskamp MJ, Wijburg FA, Wiegman A (April 2012). "Drug therapy of hypercholesterolaemia in children and adolescents". Drugs. 72 (6): 759–772. doi:10.2165/11632810-000000000-00000. PMID 22512364. S2CID 21141894.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Repas TB, Tanner JR (Februari 2014). "Preventing early cardiovascular death in patients with familial hypercholesterolemia". The Journal of the American Osteopathic Association. 114 (2): 99–108. doi:10.7556/jaoa.2014.023. PMID 24481802.
Ramasamy I (Februari 2016). "Update on the molecular biology of dyslipidemias". Clinica Chimica Acta; International Journal of Clinical Chemistry. 454: 143–185. doi:10.1016/j.cca.2015.10.033. PMID 26546829.
Rader DJ, Cohen J, Hobbs HH (Juni 2003). "Monogenic hypercholesterolemia: new insights in pathogenesis and treatment". The Journal of Clinical Investigation. 111 (12): 1795–1803. doi:10.1172/JCI18925. PMC 161432. PMID 12813012.
Marais AD, Blom DJ, Firth JC (Januari 2002). "Statins in homozygous familial hypercholesterolemia". Current Atherosclerosis Reports. 4 (1): 19–25. doi:10.1007/s11883-002-0058-7. PMID 11772418. S2CID 8075552.
Liu YH, Liu Y, Duan CY, Tan N, Chen JY, Zhou YL, et al. (Maret 2015). "Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials". Journal of Cardiovascular Pharmacology and Therapeutics. 20 (2): 181–192. doi:10.1177/1074248414549462. PMID 25193735. S2CID 28251228.
Asberg A (2003). "Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients". Drugs. 63 (4): 367–378. doi:10.2165/00003495-200363040-00003. PMID 12558459. S2CID 46971444.
Bellosta S, Paoletti R, Corsini A (Juni 2004). "Safety of statins: focus on clinical pharmacokinetics and drug interactions". Circulation. 109 (23 Suppl 1): III50–III57. doi:10.1161/01.CIR.0000131519.15067.1f. hdl:2434/143653. PMID 15198967.
Omar MA, Wilson JP (Februari 2002). "FDA adverse event reports on statin-associated rhabdomyolysis". The Annals of Pharmacotherapy. 36 (2): 288–295. doi:10.1345/aph.1A289. PMID 11847951. S2CID 43757439.
Armitage J (November 2007). "The safety of statins in clinical practice". Lancet. 370 (9601): 1781–1790. doi:10.1016/S0140-6736(07)60716-8. PMID 17559928. S2CID 205948651.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Bellosta S, Corsini A (November 2012). "Statin drug interactions and related adverse reactions". Expert Opinion on Drug Safety. 11 (6): 933–946. doi:10.1517/14740338.2012.712959. PMID 22866966. S2CID 6247572.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brault M, Ray J, Gomez YH, Mantzoros CS, Daskalopoulou SS (Juni 2014). "Statin treatment and new-onset diabetes: a review of proposed mechanisms". Metabolism. 63 (6): 735–745. doi:10.1016/j.metabol.2014.02.014. PMID 24641882.
Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, et al. (5 Mei 2020). "Drug-Induced Peripheral Neuropathy: A Narrative Review". Current Clinical Pharmacology. 15 (1): 38–48. doi:10.2174/1574884714666190121154813. PMC 7365998. PMID 30666914.
Lehrer S, Rheinstein PH (9 Juni 2020). "Statins combined with niacin reduce the risk of peripheral neuropathy". International Journal of Functional Nutrition. 1 (1). doi:10.3892/ijfn.2020.3. PMC 7737454. PMID 33330853.
Golomb BA, Evans MA (2008). "Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism". American Journal of Cardiovascular Drugs. 8 (6): 373–418. doi:10.2165/0129784-200808060-00004. PMC 2849981. PMID 19159124.
Kmietowicz Z (Maret 2014). "New analysis fuels debate on merits of prescribing statins to low risk people". BMJ. 348 g2370. doi:10.1136/bmj.g2370. PMID 24671956. S2CID 46535820.
Wise J (Juni 2014). "Open letter raises concerns about NICE guidance on statins". BMJ. 348 g3937. doi:10.1136/bmj.g3937. PMID 24920699. S2CID 42422361.
Gøtzsche PC (Juni 2014). "Muscular adverse effects are common with statins". BMJ. 348 g3724. doi:10.1136/bmj.g3724. PMID 24920687. S2CID 206902546.
Silva MA, Swanson AC, Gandhi PJ, Tataronis GR (Januari 2006). "Statin-related adverse events: a meta-analysis". Clinical Therapeutics. 28 (1): 26–35. doi:10.1016/j.clinthera.2006.01.005. PMID 16490577.
Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, et al. (2011). "Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference". The Canadian Journal of Cardiology. 27 (5): 635–662. doi:10.1016/j.cjca.2011.05.007. PMID 21963058.
Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (April 2014). "What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice". European Journal of Preventive Cardiology. 21 (4): 464–474. doi:10.1177/2047487314525531. PMID 24623264. S2CID 21064267.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Swiger KJ, Manalac RJ, Blumenthal RS, Blaha MJ, Martin SS (November 2013). "Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects". Mayo Clinic Proceedings. 88 (11): 1213–1221. doi:10.1016/j.mayocp.2013.07.013. PMID 24095248.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Mancini GB, Tashakkor AY, Baker S, Bergeron J, Fitchett D, Frohlich J, et al. (Desember 2013). "Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update". The Canadian Journal of Cardiology. 29 (12): 1553–1568. doi:10.1016/j.cjca.2013.09.023. PMID 24267801.
Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, et al. (November 2013). "Statins and cognitive function: a systematic review". Annals of Internal Medicine. 159 (10): 688–697. doi:10.7326/0003-4819-159-10-201311190-00007. PMID 24247674. S2CID 207536770.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Smith DA (Mei 2014). "ACP Journal Club. Review: statins are not associated with cognitive impairment or dementia in cognitively intact adults". Annals of Internal Medicine. 160 (10): JC11, JC10. doi:10.7326/0003-4819-160-10-201405200-02011. PMID 24842433. S2CID 1990708.
Bitzur R (Agustus 2016). "Remembering Statins: Do Statins Have Adverse Cognitive Effects?". Diabetes Care (Review). 39 (Supplement 2): S253–S259. doi:10.2337/dcS15-3022. PMID 27440840.
O'Brien EC, Greiner MA, Xian Y, Fonarow GC, Olson DM, Schwamm LH, et al. (Oktober 2015). "Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study". Circulation. 132 (15): 1404–1413. doi:10.1161/CIRCULATIONAHA.115.016183. PMID 26246175. S2CID 11252336.
McDonagh J (Desember 2014). "Statin-related cognitive impairment in the real world: you'll live longer, but you might not like it". JAMA Internal Medicine. 174 (12): 1889. doi:10.1001/jamainternmed.2014.5376. PMID 25347692.
Backes JM, Ruisinger JF, Gibson CA, Moriarty PM (Januari–Februari 2017). "Statin-associated muscle symptoms-Managing the highly intolerant". Journal of Clinical Lipidology. 11 (1): 24–33. doi:10.1016/j.jacl.2017.01.006. PMID 28391891.
Yusuf S (September 2016). "Why do people not take life-saving medications? The case of statins". Lancet. 388 (10048): 943–945. doi:10.1016/s0140-6736(16)31532-x. PMID 27598664. S2CID 34832961.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Herrett E, Williamson E, Brack K, Beaumont D, Perkins A, Thayne A, et al. (Februari 2021). "Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials". BMJ. 372: n135. doi:10.1136/bmj.n135. PMC 7903384. PMID 33627334.
Wood FA, Howard JP, Finegold JA, Nowbar AN, Thompson DM, Arnold AD, et al. (November 2020). "N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects". The New England Journal of Medicine. 383 (22): 2182–2184. doi:10.1056/NEJMc2031173. hdl:10044/1/84185. PMID 33196154. S2CID 226971988.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Colloca L, Barsky AJ (Februari 2020). "Placebo and Nocebo Effects". The New England Journal of Medicine. 382 (6): 554–561. doi:10.1056/NEJMra1907805. PMID 32023375. S2CID 211046068.
Nelson AJ, Puri R, Nissen SE (Juni 2020). "Statins in a Distorted Mirror of Media". Current Atherosclerosis Reports. 22 (8): 37. doi:10.1007/s11883-020-00853-9. PMID 32557172. S2CID 219730531.
Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. (November 2010). "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials". Lancet. 376 (9753): 1670–1681. doi:10.1016/S0140-6736(10)61350-5. PMC 2988224. PMID 21067804.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (Februari 2019). "Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–e81. doi:10.1161/ATV.0000000000000073. PMID 30580575.
Mendes P, Robles PG, Mathur S (2014). "Statin-induced rhabdomyolysis: a comprehensive review of case reports". Physiotherapy Canada. Physiotherapie Canada. 66 (2): 124–132. doi:10.3138/ptc.2012-65. PMC 4006404. PMID 24799748.
Potgieter M, Pretorius E, Pepper MS (Maret 2013). "Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation". Nutrition Reviews. 71 (3): 180–188. doi:10.1111/nure.12011. PMID 23452285.
Tan JT, Barry AR (Juni 2017). "Coenzyme Q10 supplementation in the management of statin-associated myalgia". American Journal of Health-System Pharmacy. 74 (11): 786–793. doi:10.2146/ajhp160714. PMID 28546301. S2CID 3825396.
Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, et al. (Agustus 2008). "SLCO1B1 variants and statin-induced myopathy--a genomewide study". The New England Journal of Medicine. 359 (8): 789–799. doi:10.1056/NEJMoa0801936. PMID 18650507.
Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, et al. (Desember 2004). "Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs". JAMA. 292 (21): 2585–2590. doi:10.1001/jama.292.21.2585. PMID 15572716.
Backman JT, Filppula AM, Niemi M, Neuvonen PJ (Januari 2016). "Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions". Pharmacological Reviews (Review). 68 (1): 168–241. doi:10.1124/pr.115.011411. PMID 26721703.
Hanai J, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, et al. (Desember 2007). "The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity". The Journal of Clinical Investigation. 117 (12): 3940–3951. doi:10.1172/JCI32741. PMC 2066198. PMID 17992259.
Teichtahl AJ, Brady SR, Urquhart DM, Wluka AE, Wang Y, Shaw JE, et al. (Februari 2016). "Statins and tendinopathy: a systematic review". The Medical Journal of Australia. 204 (3): 115–21.e1. doi:10.5694/mja15.00806. PMID 26866552. S2CID 4652858.
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. (Februari 2010). "Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials". Lancet. 375 (9716): 735–742. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. S2CID 11544414.
Chou R, Dana T, Blazina I, Daeges M, Jeanne TL (November 2016). "Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force". JAMA (Review). 316 (19): 2008–2024. doi:10.1001/jama.2015.15629. PMID 27838722.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Rochlani Y, Kattoor AJ, Pothineni NV, Palagiri RD, Romeo F, Mehta JL (Oktober 2017). "Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention". The American Journal of Cardiology (Review). 120 (7): 1122–1128. Bibcode:1981AmJC...48..728H. doi:10.1016/j.amjcard.2017.06.054. PMID 28797470.
He Y, Li X, Gasevic D, Brunt E, McLachlan F, Millenson M, et al. (Oktober 2018). "Statins and Multiple Noncardiovascular Outcomes: Umbrella Review of Meta-analyses of Observational Studies and Randomized Controlled Trials". Annals of Internal Medicine. 169 (8): 543–553. doi:10.7326/M18-0808. PMID 30304368. S2CID 52953760.
Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. (Juni 2011). "Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis". JAMA. 305 (24): 2556–2564. doi:10.1001/jama.2011.860. hdl:10044/1/39305. PMID 21693744.
Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, et al. (Januari 2012). "Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative". Archives of Internal Medicine. 172 (2): 144–152. doi:10.1001/archinternmed.2011.625. PMID 22231607.
Carmena R, Betteridge DJ (April 2019). "Diabetogenic Action of Statins: Mechanisms". Current Atherosclerosis Reports. 21 (6): 23. doi:10.1007/s11883-019-0780-z. PMID 31037345. S2CID 140506916.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S (September 2012). "The controversies of statin therapy: weighing the evidence". Journal of the American College of Cardiology. 60 (10): 875–881. doi:10.1016/j.jacc.2012.07.007. PMID 22902202.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Rutishauser J (21 November 2011). "Statins in clinical medicine". Swiss Medical Weekly. 141: w13310. doi:10.4414/smw.2011.13310. PMID 22101921.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH (Juli 2007). "Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials". Journal of the American College of Cardiology. 50 (5): 409–418. doi:10.1016/j.jacc.2007.02.073. PMID 17662392.
Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (Januari 2006). "Statins and cancer risk: a meta-analysis". JAMA. 295 (1): 74–80. doi:10.1001/jama.295.1.74. PMID 16391219.
Alsheikh-Ali AA, Karas RH (Maret 2009). "The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials". Current Atherosclerosis Reports. 11 (2): 100–104. doi:10.1007/s11883-009-0016-8. PMID 19228482. S2CID 42869773.
Singh S, Singh AG, Singh PP, Murad MH, Iyer PG (Juni 2013). "Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis". Clinical Gastroenterology and Hepatology. 11 (6): 620–629. doi:10.1016/j.cgh.2012.12.036. PMC 3660516. PMID 23357487.
Liu Y, Tang W, Wang J, Xie L, Li T, He Y, et al. (Februari 2014). "Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies". Cancer Causes & Control. 25 (2): 237–249. doi:10.1007/s10552-013-0326-6. PMID 24265089. S2CID 17931279.
Wu XD, Zeng K, Xue FQ, Chen JH, Chen YQ (Oktober 2013). "Statins are associated with reduced risk of gastric cancer: a meta-analysis". European Journal of Clinical Pharmacology. 69 (10): 1855–1860. doi:10.1007/s00228-013-1547-z. PMID 23748751. S2CID 16584300.
Singh PP, Singh S (Juli 2013). "Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis". Annals of Oncology. 24 (7): 1721–1730. doi:10.1093/annonc/mdt150. PMID 23599253.
Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, et al. (Mei 2013). "Statins and primary liver cancer: a meta-analysis of observational studies". European Journal of Cancer Prevention. 22 (3): 229–234. doi:10.1097/cej.0b013e328358761a. PMID 23010949. S2CID 37195287.
Zhang Y, Zang T (2013). "Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005-2010". Urologia Internationalis. 90 (3): 259–262. doi:10.1159/000341977. PMID 23052323. S2CID 22078921.
Bansal D, Undela K, D'Cruz S, Schifano F (2012). "Statin use and risk of prostate cancer: a meta-analysis of observational studies". PLOS ONE. 7 (10) e46691. Bibcode:2012PLoSO...746691B. doi:10.1371/journal.pone.0046691. PMC 3462187. PMID 23049713.
Tan M, Song X, Zhang G, Peng A, Li X, Li M, et al. (2013). "Statins and the risk of lung cancer: a meta-analysis". PLOS ONE. 8 (2) e57349. Bibcode:2013PLoSO...857349T. doi:10.1371/journal.pone.0057349. PMC 3585354. PMID 23468972.
Zhang XL, Liu M, Qian J, Zheng JH, Zhang XP, Guo CC, et al. (Maret 2014). "Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials". British Journal of Clinical Pharmacology. 77 (3): 458–465. doi:10.1111/bcp.12210. PMC 3952720. PMID 23879311.
Undela K, Srikanth V, Bansal D (Agustus 2012). "Statin use and risk of breast cancer: a meta-analysis of observational studies". Breast Cancer Research and Treatment. 135 (1): 261–269. doi:10.1007/s10549-012-2154-x. PMID 22806241. S2CID 35249884.
Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, et al. (Juli 2012). "Statin use and risk of pancreatic cancer: a meta-analysis". Cancer Causes & Control. 23 (7): 1099–1111. doi:10.1007/s10552-012-9979-9. PMID 22562222. S2CID 13171692.
Zhang XL, Geng J, Zhang XP, Peng B, Che JP, Yan Y, et al. (April 2013). "Statin use and risk of bladder cancer: a meta-analysis". Cancer Causes & Control. 24 (4): 769–776. doi:10.1007/s10552-013-0159-3. PMID 23361339. S2CID 9030195.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (2019). "Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–e81. doi:10.1161/ATV.0000000000000073. ISSN 1079-5642. PMID 30580575. Diarsipkan dari versi aslinya tanggal 28 Mei 2024. Diakses tanggal 14 Mei 2024.
Kane GC, Lipsky JJ (September 2000). "Drug-grapefruit juice interactions". Mayo Clinic Proceedings. 75 (9): 933–942. doi:10.4065/75.9.933. PMID 10994829.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Reamy BV, Stephens MB (Juli 2007). "The grapefruit-drug interaction debate: role of statins". American Family Physician. 76 (2): 190, 192, author reply 192. PMID 17695563. Diarsipkan dari versi aslinya tanggal 10 November 2018. Diakses tanggal 29 April 2012.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Lin TK, Chou P, Lin CH, Hung YJ, Jong GP (2018). "Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study". PLOS ONE. 13 (5) e0196713. Bibcode:2018PLoSO..1396713L. doi:10.1371/journal.pone.0196713. PMC 5933736. PMID 29723231.
Wang Z, Li Y, Zhou F, Piao Z, Hao J (Mei 2016). "Effects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-Analysis". Medicine. 95 (22) e3042. doi:10.1097/MD.0000000000003042. PMC 4900696. PMID 27258488.
An T, Hao J, Sun S, Li R, Yang M, Cheng G, et al. (Januari 2017). "Efficacy of statins for osteoporosis: a systematic review and meta-analysis". Osteoporosis International. 28 (1): 47–57. doi:10.1007/s00198-016-3844-8. PMID 27888285. S2CID 4723680.
Larsson BA, Sundh D, Mellström D, Axelsson KF, Nilsson AG, Lorentzon M (Februari 2019). "Association Between Cortical Bone Microstructure and Statin Use in Older Women". The Journal of Clinical Endocrinology and Metabolism. 104 (2): 250–257. doi:10.1210/jc.2018-02054. PMID 30423123.
Leutner M, Matzhold C, Bellach L, Deischinger C, Harreiter J, Thurner S, et al. (Desember 2019). "Diagnosis of osteoporosis in statin-treated patients is dose-dependent". Annals of the Rheumatic Diseases. 78 (12): 1706–1711. doi:10.1136/annrheumdis-2019-215714. PMC 6900255. PMID 31558481.
Istvan ES, Deisenhofer J (Mei 2001). "Structural mechanism for statin inhibition of HMG-CoA reductase". Science. 292 (5519): 1160–1164. Bibcode:2001Sci...292.1160I. doi:10.1126/science.1059344. PMID 11349148. S2CID 37686043.
Miettinen TA (Maret 1982). "Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins". Journal of Lipid Research. 23 (3): 466–473. doi:10.1016/S0022-2275(20)38144-X. PMID 7200504.
Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y (Juli–Agustus 1991). "Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study". Arteriosclerosis and Thrombosis. 11 (4): 816–826. doi:10.1161/01.ATV.11.4.816. PMID 2065035.
Wallace A, Chinn D, Rubin G (Oktober 2003). "Taking simvastatin in the morning compared with in the evening: randomised controlled trial". BMJ. 327 (7418): 788. doi:10.1136/bmj.327.7418.788. PMC 214096. PMID 14525878.
Cilla DD, Gibson DM, Whitfield LR, Sedman AJ (Juli 1996). "Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening". Journal of Clinical Pharmacology. 36 (7): 604–609. doi:10.1002/j.1552-4604.1996.tb04224.x. PMID 8844442. S2CID 13586550.
Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstein JL, Brown MS (November 1986). "Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits". Proceedings of the National Academy of Sciences of the United States of America. 83 (21): 8370–8374. Bibcode:1986PNAS...83.8370M. doi:10.1073/pnas.83.21.8370. PMC 386930. PMID 3464957.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Laufs U, Custodis F, Böhm M (2006). "HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk". Drugs. 66 (2): 145–154. doi:10.2165/00003495-200666020-00002. PMID 16451090. S2CID 46985044.
Greenwood J, Steinman L, Zamvil SS (Mei 2006). "Statin therapy and autoimmune disease: from protein prenylation to immunomodulation". Nature Reviews. Immunology. 6 (5): 358–370. doi:10.1038/nri1839. PMC 3842637. PMID 16639429.
Lahera V, Goicoechea M, de Vinuesa SG, Miana M, de las Heras N, Cachofeiro V, et al. (2007). "Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins". Current Medicinal Chemistry. 14 (2): 243–248. doi:10.2174/092986707779313381. PMID 17266583.
Blum A, Shamburek R (April 2009). "The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis". Atherosclerosis. 203 (2): 325–330. doi:10.1016/j.atherosclerosis.2008.08.022. PMID 18834985.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Porter KE, Turner NA (Juli 2011). "Statins and myocardial remodelling: cell and molecular pathways". Expert Reviews in Molecular Medicine. 13 (e22): e22. doi:10.1017/S1462399411001931. PMID 21718586. S2CID 1975524.
Sawada N, Liao JK (Maret 2014). "Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis". Antioxidants & Redox Signaling. 20 (8): 1251–1267. doi:10.1089/ars.2013.5524. PMC 3934442. PMID 23919640.
Thurnher M, Nussbaumer O, Gruenbacher G (Juli 2012). "Novel aspects of mevalonate pathway inhibitors as antitumor agents". Clinical Cancer Research. 18 (13): 3524–3531. doi:10.1158/1078-0432.CCR-12-0489. PMID 22529099.
Norata GD, Tibolla G, Catapano AL (Oktober 2014). "Statins and skeletal muscles toxicity: from clinical trials to everyday practice". Pharmacological Research. 88: 107–113. doi:10.1016/j.phrs.2014.04.012. PMID 24835295.
Kowluru A (Januari 2008). "Protein prenylation in glucose-induced insulin secretion from the pancreatic islet beta cell: a perspective". Journal of Cellular and Molecular Medicine. 12 (1): 164–173. doi:10.1111/j.1582-4934.2007.00168.x. PMC 3823478. PMID 18053094.
Liao JK, Laufs U (2005). "Pleiotropic effects of statins". Annual Review of Pharmacology and Toxicology. 45: 89–118. doi:10.1146/annurev.pharmtox.45.120403.095748. PMC 2694580. PMID 15822172.
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. (April 2006). "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial". JAMA. 295 (13): 1556–1565. doi:10.1001/jama.295.13.jpc60002. PMID 16533939.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. (November 2008). "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein". The New England Journal of Medicine. 359 (21): 2195–2207. doi:10.1056/NEJMoa0807646. PMID 18997196.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Kones R (Desember 2010). "Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease—a perspective". Drug Design, Development and Therapy. 4: 383–413. doi:10.2147/DDDT.S10812. PMC 3023269. PMID 21267417.
Ferdinand KC (Februari 2011). "Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?". Current Atherosclerosis Reports. 13 (1): 64–72. doi:10.1007/s11883-010-0149-9. PMID 21104458. S2CID 32142669.
Devaraj S, Siegel D, Jialal I (Februari 2011). "Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?". Current Atherosclerosis Reports. 13 (1): 31–42. doi:10.1007/s11883-010-0143-2. PMC 3018293. PMID 21046291.
Ridker PM, Glynn RJ (November 2010). "The JUPITER Trial: responding to the critics". The American Journal of Cardiology. 106 (9): 1351–1356. doi:10.1016/j.amjcard.2010.08.025. PMID 21029837.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Vögeli B, Shima S, Erb TJ, Wagner T (Maret 2019). "Crystal structure of archaeal HMG-CoA reductase: insights into structural changes of the C-terminal helix of the class-I enzyme". FEBS Letters. 593 (5): 543–553. doi:10.1002/1873-3468.13331. PMID 30702149. S2CID 73412833.
Gottlieb K, Wacher V, Sliman J, Pimentel M (Januari 2016). "Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders". Alimentary Pharmacology & Therapeutics. 43 (2): 197–212. doi:10.1111/apt.13469. PMC 4737270. PMID 26559904.
Lurie-Weinberger MN, Gophna U (Juni 2015). "Archaea in and on the Human Body: Health Implications and Future Directions". PLOS Pathogens. 11 (6) e1004833. doi:10.1371/journal.ppat.1004833. PMC 4466265. PMID 26066650.
Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, et al. (Maret 1997). "Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved". Drug Metabolism and Disposition. 25 (3): 321–331. PMID 9172950.
Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, et al. (Februari 1999). "Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver". Drug Metabolism and Disposition. 27 (2): 173–179. doi:10.1016/S0090-9556(24)15273-7. PMID 9929499. Diarsipkan dari asli tanggal 26 Agustus 2021. Diakses tanggal 8 November 2018.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG (Maret 2003). "Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals". The American Journal of Cardiology. 91 (5A): 11C–17C, discussion 17C–19C. doi:10.1016/S0002-9149(03)00004-3. PMID 12646338.
Baldinelli L, Biselli R, Fattorossi A (Februari 2005). "Influence of ST 789 on murine thymocytes: a flow cytometry study of thymocyte subset distribution and of intracellular free Ca++ increase upon activation. Murine thymocytes and ST 789". Thymus. 19 (2 Suppl 1): S53–S61. doi:10.1111/j.1742-1241.2005.00461.x. PMID 1585420. S2CID 221814440.
Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V (November 2006). "Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials". Chinese Medicine. 1 (1): 4. doi:10.1186/1749-8546-1-4. PMC 1761143. PMID 17302963.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM (19 Januari 2012). "Generic Atorvastatin and Health Care Costs". New England Journal of Medicine. 366 (3): 201–204. doi:10.1056/NEJMp1113112. ISSN 0028-4793. PMC 3319770. PMID 22149736.
Wolozin B, Wang SW, Li NC, Lee A, Lee TA, Kazis LE (Juli 2007). "Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease". BMC Medicine. 5 (1): 20. doi:10.1186/1741-7015-5-20. PMC 1955446. PMID 17640385.
Khurana V, Bejjanki HR, Caldito G, Owens MW (Mei 2007). "Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans". Chest. 131 (5): 1282–1288. doi:10.1378/chest.06-0931. PMID 17494779.
Klein BE, Klein R, Lee KE, Grady LM (Juni 2006). "Statin use and incident nuclear cataract". JAMA. 295 (23): 2752–2758. doi:10.1001/jama.295.23.2752. PMID 16788130.
Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH (April 2008). "Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial". Archives of Internal Medicine. 168 (7): 721–727. doi:10.1001/archinte.168.7.721. PMC 4285458. PMID 18413554.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Drapala A, Sikora M, Ufnal M (September 2014). "Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins". Journal of the Renin-Angiotensin-Aldosterone System. 15 (3): 250–258. doi:10.1177/1470320314531058. PMID 25037529.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Mondul AM, Han M, Humphreys EB, Meinhold CL, Walsh PC, Platz EA (April 2011). "Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery". The Journal of Urology. 185 (4): 1268–1273. doi:10.1016/j.juro.2010.11.089. PMC 3584560. PMID 21334020.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Liu B, Yi Z, Guan X, Zeng YX, Ma F (Juli 2017). "The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis". Breast Cancer Research and Treatment. 164 (1): 1–11. doi:10.1007/s10549-017-4246-0. PMID 28432513. S2CID 3900946.
Batais MA, Khan AR, Bin Abdulhak AA (Agustus 2017). "The Use of Statins and Risk of Community-Acquired Pneumonia". Current Infectious Disease Reports. 19 (8): 26. doi:10.1007/s11908-017-0581-x. PMID 28639080. S2CID 20522253.
Wang J, Xiao Y, Luo M, Luo H (Desember 2011). "Statins for multiple sclerosis". The Cochrane Database of Systematic Reviews. 2011 (12) CD008386. doi:10.1002/14651858.CD008386.pub3. PMC 7175839. PMID 22161428.
Gutlapalli SD, Farhat H, Irfan H, Muthiah K, Pallipamu N, Taheri S, et al. (2022). "The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022". Cureus. 14 (12) e32323. doi:10.7759/cureus.32323. ISSN 2168-8184. PMC 9825119. PMID 36628002.
Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, et al. (1 November 2024). "Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study". Heart (dalam bahasa Inggris). 110 (21): 1277–1285. doi:10.1136/heartjnl-2024-324052. ISSN 1355-6037. PMC 11503164. PMID 39256053.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

ncbi.nlm.nih.gov

Alenghat FJ, Davis AM (Februari 2019). "Management of Blood Cholesterol". JAMA. 321 (8): 800–801. doi:10.1001/jama.2019.0015. PMC 6679800. PMID 30715135.
National Clinical Guideline Centre (UK) (Juli 2014). Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. National Institute for Health and Clinical Excellence: Guidance. London: National Institute for Health and Care Excellence (UK). PMID 25340243. NICE Clinical Guidelines, No. 181. Diarsipkan dari versi aslinya tanggal 29 Mei 2020. Diakses tanggal 26 April 2020 – via National Library of Medicine.{{cite book}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. (Januari 2013). "Statins for the primary prevention of cardiovascular disease". The Cochrane Database of Systematic Reviews. 2013 (1) CD004816. doi:10.1002/14651858.CD004816.pub5. PMC 6481400. PMID 23440795.
Maningat P, Gordon BR, Breslow JL (Januari 2013). "How do we improve patient compliance and adherence to long-term statin therapy?". Current Atherosclerosis Reports. 15 (1): 291. doi:10.1007/s11883-012-0291-7. PMC 3534845. PMID 23225173.
Tarn D, Pletcher M, Tosqui R (Juni 2021). "Primary nonadherence to statin medications: Survey of patient perspectives". Preventive Medicine Reports. 22 101357. doi:10.1016/j.pmedr.2021.101357. PMC 8020471. PMID 33842201.
Goldstein JL, Brown MS (Maret 2015). "A century of cholesterol and coronaries: from plaques to genes to statins". Cell. 161 (1): 161–172. doi:10.1016/j.cell.2015.01.036. PMC 4525717. PMID 25815993.
Endo A (2010). "A historical perspective on the discovery of statins". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (5): 484–493. Bibcode:2010PJAB...86..484E. doi:10.2183/pjab.86.484. PMC 3108295. PMID 20467214.
Ko HH, Lareu RR, Dix BR, Hughes JD (24 Oktober 2017). "Statins: antimicrobial resistance breakers or makers?". PeerJ. 5 e3952. doi:10.7717/peerj.3952. ISSN 2167-8359. PMC 5659212. PMID 29085751.
Gesto DS, Pereira CM, Cerqueira NM, Sousa SF (26 Agustus 2020). "An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia". Molecules. 25 (17): 3891. doi:10.3390/molecules25173891. ISSN 1420-3049. PMC 7503714. PMID 32859023.
Tunnicliffe DJ, Palmer SC, Cashmore BA, Saglimbene VM, Krishnasamy R, Lambert K, et al. (29 November 2023). "HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis". The Cochrane Database of Systematic Reviews. 11 (11) CD007784. doi:10.1002/14651858.CD007784.pub3. ISSN 1469-493X. PMC 10685396. PMID 38018702.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Byrne P, Demasi M, Jones M, Smith SM, O'Brien KK, DuBroff R (Mei 2022). "Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 182 (5): 474–481. doi:10.1001/jamainternmed.2022.0134. PMC 8922205. PMID 35285850.
Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, et al. (Februari 2019). "Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials". Lancet. 393 (10170): 407–415. doi:10.1016/S0140-6736(18)31942-1. PMC 6429627. PMID 30712900.
Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, et al. (November 2011). "Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis". CMAJ. 183 (16): E1189–E1202. doi:10.1503/cmaj.101280. PMC 3216447. PMID 21989464.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Law MR, Wald NJ, Rudnicka AR (Juni 2003). "Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis". BMJ. 326 (7404): 1423–0. doi:10.1136/bmj.326.7404.1423. PMC 162260. PMID 12829554.
Khera AV, Plutzky J (Juli 2013). "Management of low levels of high-density lipoprotein-cholesterol". Circulation (Review). 128 (1): 72–78. doi:10.1161/CIRCULATIONAHA.112.000443. PMC 4231714. PMID 23817482.
Mijajlović MD, Pavlović A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, et al. (Januari 2017). "Post-stroke dementia - a comprehensive review". BMC Medicine. 15 (1): 11. doi:10.1186/s12916-017-0779-7. PMC 5241961. PMID 28095900.
Sladojevic N, Yu B, Liao JK (Desember 2017). "ROCK as a therapeutic target for ischemic stroke". Expert Review of Neurotherapeutics. 17 (12): 1167–1177. doi:10.1080/14737175.2017.1395700. PMC 6221831. PMID 29057688.
Sheng X, Murphy MJ, MacDonald TM, Wei L (30 Agustus 2012). "The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population". BMC Public Health. 12 (1): 712. doi:10.1186/1471-2458-12-712. ISSN 1471-2458. PMC 3490740. PMID 22935195.
Bansal AB, Cassagnol M (2023), "HMG-CoA Reductase Inhibitors", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31194369, diakses tanggal 11 November 2023{{citation}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Zhang X, Xing L, Jia X, Pang X, Xiang Q, Zhao X, et al. (27 April 2020). "Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials". Cardiovascular Therapeutics. 2020 e3987065. doi:10.1155/2020/3987065. ISSN 1755-5914. PMC 7201823. PMID 32411300.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Adams SP, Tsang M, Wright JM (Maret 2015). "Lipid-lowering efficacy of atorvastatin". The Cochrane Database of Systematic Reviews. 2015 (3) CD008226. doi:10.1002/14651858.CD008226.pub3. PMC 6464917. PMID 25760954.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, et al. (November 2019). "Statins for children with familial hypercholesterolemia". The Cochrane Database of Systematic Reviews. 2019 (11). doi:10.1002/14651858.CD006401.pub5. PMC 6836374. PMID 31696945.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Rader DJ, Cohen J, Hobbs HH (Juni 2003). "Monogenic hypercholesterolemia: new insights in pathogenesis and treatment". The Journal of Clinical Investigation. 111 (12): 1795–1803. doi:10.1172/JCI18925. PMC 161432. PMID 12813012.
Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, et al. (5 Mei 2020). "Drug-Induced Peripheral Neuropathy: A Narrative Review". Current Clinical Pharmacology. 15 (1): 38–48. doi:10.2174/1574884714666190121154813. PMC 7365998. PMID 30666914.
Lehrer S, Rheinstein PH (9 Juni 2020). "Statins combined with niacin reduce the risk of peripheral neuropathy". International Journal of Functional Nutrition. 1 (1). doi:10.3892/ijfn.2020.3. PMC 7737454. PMID 33330853.
Golomb BA, Evans MA (2008). "Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism". American Journal of Cardiovascular Drugs. 8 (6): 373–418. doi:10.2165/0129784-200808060-00004. PMC 2849981. PMID 19159124.
Herrett E, Williamson E, Brack K, Beaumont D, Perkins A, Thayne A, et al. (Februari 2021). "Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials". BMJ. 372: n135. doi:10.1136/bmj.n135. PMC 7903384. PMID 33627334.
Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. (November 2010). "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials". Lancet. 376 (9753): 1670–1681. doi:10.1016/S0140-6736(10)61350-5. PMC 2988224. PMID 21067804.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Mendes P, Robles PG, Mathur S (2014). "Statin-induced rhabdomyolysis: a comprehensive review of case reports". Physiotherapy Canada. Physiotherapie Canada. 66 (2): 124–132. doi:10.3138/ptc.2012-65. PMC 4006404. PMID 24799748.
Hanai J, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, et al. (Desember 2007). "The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity". The Journal of Clinical Investigation. 117 (12): 3940–3951. doi:10.1172/JCI32741. PMC 2066198. PMID 17992259.
Singh S, Singh AG, Singh PP, Murad MH, Iyer PG (Juni 2013). "Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis". Clinical Gastroenterology and Hepatology. 11 (6): 620–629. doi:10.1016/j.cgh.2012.12.036. PMC 3660516. PMID 23357487.
Bansal D, Undela K, D'Cruz S, Schifano F (2012). "Statin use and risk of prostate cancer: a meta-analysis of observational studies". PLOS ONE. 7 (10) e46691. Bibcode:2012PLoSO...746691B. doi:10.1371/journal.pone.0046691. PMC 3462187. PMID 23049713.
Tan M, Song X, Zhang G, Peng A, Li X, Li M, et al. (2013). "Statins and the risk of lung cancer: a meta-analysis". PLOS ONE. 8 (2) e57349. Bibcode:2013PLoSO...857349T. doi:10.1371/journal.pone.0057349. PMC 3585354. PMID 23468972.
Zhang XL, Liu M, Qian J, Zheng JH, Zhang XP, Guo CC, et al. (Maret 2014). "Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials". British Journal of Clinical Pharmacology. 77 (3): 458–465. doi:10.1111/bcp.12210. PMC 3952720. PMID 23879311.
Lin TK, Chou P, Lin CH, Hung YJ, Jong GP (2018). "Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study". PLOS ONE. 13 (5) e0196713. Bibcode:2018PLoSO..1396713L. doi:10.1371/journal.pone.0196713. PMC 5933736. PMID 29723231.
Wang Z, Li Y, Zhou F, Piao Z, Hao J (Mei 2016). "Effects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-Analysis". Medicine. 95 (22) e3042. doi:10.1097/MD.0000000000003042. PMC 4900696. PMID 27258488.
Leutner M, Matzhold C, Bellach L, Deischinger C, Harreiter J, Thurner S, et al. (Desember 2019). "Diagnosis of osteoporosis in statin-treated patients is dose-dependent". Annals of the Rheumatic Diseases. 78 (12): 1706–1711. doi:10.1136/annrheumdis-2019-215714. PMC 6900255. PMID 31558481.
Wallace A, Chinn D, Rubin G (Oktober 2003). "Taking simvastatin in the morning compared with in the evening: randomised controlled trial". BMJ. 327 (7418): 788. doi:10.1136/bmj.327.7418.788. PMC 214096. PMID 14525878.
Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstein JL, Brown MS (November 1986). "Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits". Proceedings of the National Academy of Sciences of the United States of America. 83 (21): 8370–8374. Bibcode:1986PNAS...83.8370M. doi:10.1073/pnas.83.21.8370. PMC 386930. PMID 3464957.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Greenwood J, Steinman L, Zamvil SS (Mei 2006). "Statin therapy and autoimmune disease: from protein prenylation to immunomodulation". Nature Reviews. Immunology. 6 (5): 358–370. doi:10.1038/nri1839. PMC 3842637. PMID 16639429.
Sawada N, Liao JK (Maret 2014). "Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis". Antioxidants & Redox Signaling. 20 (8): 1251–1267. doi:10.1089/ars.2013.5524. PMC 3934442. PMID 23919640.
Kowluru A (Januari 2008). "Protein prenylation in glucose-induced insulin secretion from the pancreatic islet beta cell: a perspective". Journal of Cellular and Molecular Medicine. 12 (1): 164–173. doi:10.1111/j.1582-4934.2007.00168.x. PMC 3823478. PMID 18053094.
Liao JK, Laufs U (2005). "Pleiotropic effects of statins". Annual Review of Pharmacology and Toxicology. 45: 89–118. doi:10.1146/annurev.pharmtox.45.120403.095748. PMC 2694580. PMID 15822172.
Kones R (Desember 2010). "Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease—a perspective". Drug Design, Development and Therapy. 4: 383–413. doi:10.2147/DDDT.S10812. PMC 3023269. PMID 21267417.
Devaraj S, Siegel D, Jialal I (Februari 2011). "Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?". Current Atherosclerosis Reports. 13 (1): 31–42. doi:10.1007/s11883-010-0143-2. PMC 3018293. PMID 21046291.
Gottlieb K, Wacher V, Sliman J, Pimentel M (Januari 2016). "Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders". Alimentary Pharmacology & Therapeutics. 43 (2): 197–212. doi:10.1111/apt.13469. PMC 4737270. PMID 26559904.
Lurie-Weinberger MN, Gophna U (Juni 2015). "Archaea in and on the Human Body: Health Implications and Future Directions". PLOS Pathogens. 11 (6) e1004833. doi:10.1371/journal.ppat.1004833. PMC 4466265. PMID 26066650.
Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V (November 2006). "Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials". Chinese Medicine. 1 (1): 4. doi:10.1186/1749-8546-1-4. PMC 1761143. PMID 17302963.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM (19 Januari 2012). "Generic Atorvastatin and Health Care Costs". New England Journal of Medicine. 366 (3): 201–204. doi:10.1056/NEJMp1113112. ISSN 0028-4793. PMC 3319770. PMID 22149736.
Wolozin B, Wang SW, Li NC, Lee A, Lee TA, Kazis LE (Juli 2007). "Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease". BMC Medicine. 5 (1): 20. doi:10.1186/1741-7015-5-20. PMC 1955446. PMID 17640385.
Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH (April 2008). "Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial". Archives of Internal Medicine. 168 (7): 721–727. doi:10.1001/archinte.168.7.721. PMC 4285458. PMID 18413554.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Mondul AM, Han M, Humphreys EB, Meinhold CL, Walsh PC, Platz EA (April 2011). "Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery". The Journal of Urology. 185 (4): 1268–1273. doi:10.1016/j.juro.2010.11.089. PMC 3584560. PMID 21334020.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Wang J, Xiao Y, Luo M, Luo H (Desember 2011). "Statins for multiple sclerosis". The Cochrane Database of Systematic Reviews. 2011 (12) CD008386. doi:10.1002/14651858.CD008386.pub3. PMC 7175839. PMID 22161428.
Gutlapalli SD, Farhat H, Irfan H, Muthiah K, Pallipamu N, Taheri S, et al. (2022). "The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022". Cureus. 14 (12) e32323. doi:10.7759/cureus.32323. ISSN 2168-8184. PMC 9825119. PMID 36628002.
Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, et al. (1 November 2024). "Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study". Heart (dalam bahasa Inggris). 110 (21): 1277–1285. doi:10.1136/heartjnl-2024-324052. ISSN 1355-6037. PMC 11503164. PMID 39256053.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

nihr.ac.uk (Global: low place; Indonesian: low place)

evidence.nihr.ac.uk

"Older people who take statins live longer in better health". NIHR Evidence. 2025. doi:10.3310/nihrevidence_65725. Diakses tanggal 22 Januari 2025.

nytimes.com (Global: 7^th place; Indonesian: 20^th place)

"Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca". The New York Times. 21 Juli 2016. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.
Wilson D (6 Maret 2011). "Drug Firms Face Billions in Losses as Patents End". The New York Times. Diarsipkan dari versi aslinya tanggal 22 November 2019. Diakses tanggal 31 Oktober 2019.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Berenson A (23 Juni 2006). "Merck Loses Protection for Patent on Zocor". The New York Times. Diarsipkan dari versi aslinya tanggal 14 Januari 2015. Diakses tanggal 31 Oktober 2019.

patient.co.uk (Global: low place; Indonesian: low place)

Rull R, Henderson R (20 Januari 2015). "Rhabdomyolysis and Other Causes of Myoglobinuria". Diarsipkan dari asli tanggal 7 Mei 2015. Diakses tanggal 6 Mei 2015.

semanticscholar.org (Global: 15^th place; Indonesian: 26^th place)

api.semanticscholar.org

Naci H, Brugts J, Ades T (Juli 2013). "Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials". Circulation: Cardiovascular Quality and Outcomes. 6 (4): 390–399. doi:10.1161/CIRCOUTCOMES.111.000071. PMID 23838105. S2CID 18340552.
Abd TT, Jacobson TA (Mei 2011). "Statin-induced myopathy: a review and update". Expert Opinion on Drug Safety. 10 (3): 373–387. doi:10.1517/14740338.2011.540568. PMID 21342078. S2CID 207487287.
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. (Desember 2007). "Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths". The Lancet. 370 (9602): 1829–1839. doi:10.1016/S0140-6736(07)61778-4. PMID 18061058. S2CID 54293528.
Scandinaviansimvastatinsurvival (November 1994). "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)". Lancet. 344 (8934): 1383–1389. doi:10.1016/S0140-6736(94)90566-5. PMID 7968073. S2CID 5965882.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. (November 2016). "Interpretation of the evidence for the efficacy and safety of statin therapy". Lancet (Submitted manuscript). 388 (10059): 2532–2561. doi:10.1016/S0140-6736(16)31357-5. hdl:10044/1/43661. PMID 27616593. S2CID 4641278.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. (April 2015). "Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials". The Lancet. 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID 25579834. S2CID 35330627.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cangemi R, Romiti GF, Campolongo G, Ruscio E, Sciomer S, Gianfrilli D, et al. (Maret 2017). "Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate". Pharmacological Research. 117: 148–155. doi:10.1016/j.phrs.2016.12.027. PMID 28012963. S2CID 32861954.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, et al. (November 2016). "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 316 (19): 1997–2007. doi:10.1001/jama.2016.15450. PMID 27838723. S2CID 205075217.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Pisaniello AD, Scherer DJ, Kataoka Y, Nicholls SJ (Februari 2015). "Ongoing challenges for pharmacotherapy for dyslipidemia". Expert Opinion on Pharmacotherapy. 16 (3): 347–356. doi:10.1517/14656566.2014.986094. PMID 25476544. S2CID 539314.
Kushner PA, Cobble ME (November 2016). "Hypertriglyceridemia: the importance of identifying patients at risk". Postgraduate Medicine (Review). 128 (8): 848–858. doi:10.1080/00325481.2016.1243005. PMID 27710158. S2CID 45663315.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V (September 2013). "The safety of statins in children". Acta Paediatrica. 102 (9): 857–862. doi:10.1111/apa.12280. PMID 23631461. S2CID 22846175.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Braamskamp MJ, Wijburg FA, Wiegman A (April 2012). "Drug therapy of hypercholesterolaemia in children and adolescents". Drugs. 72 (6): 759–772. doi:10.2165/11632810-000000000-00000. PMID 22512364. S2CID 21141894.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Marais AD, Blom DJ, Firth JC (Januari 2002). "Statins in homozygous familial hypercholesterolemia". Current Atherosclerosis Reports. 4 (1): 19–25. doi:10.1007/s11883-002-0058-7. PMID 11772418. S2CID 8075552.
Liu YH, Liu Y, Duan CY, Tan N, Chen JY, Zhou YL, et al. (Maret 2015). "Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials". Journal of Cardiovascular Pharmacology and Therapeutics. 20 (2): 181–192. doi:10.1177/1074248414549462. PMID 25193735. S2CID 28251228.
Asberg A (2003). "Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients". Drugs. 63 (4): 367–378. doi:10.2165/00003495-200363040-00003. PMID 12558459. S2CID 46971444.
Omar MA, Wilson JP (Februari 2002). "FDA adverse event reports on statin-associated rhabdomyolysis". The Annals of Pharmacotherapy. 36 (2): 288–295. doi:10.1345/aph.1A289. PMID 11847951. S2CID 43757439.
Armitage J (November 2007). "The safety of statins in clinical practice". Lancet. 370 (9601): 1781–1790. doi:10.1016/S0140-6736(07)60716-8. PMID 17559928. S2CID 205948651.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Bellosta S, Corsini A (November 2012). "Statin drug interactions and related adverse reactions". Expert Opinion on Drug Safety. 11 (6): 933–946. doi:10.1517/14740338.2012.712959. PMID 22866966. S2CID 6247572.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Kmietowicz Z (Maret 2014). "New analysis fuels debate on merits of prescribing statins to low risk people". BMJ. 348 g2370. doi:10.1136/bmj.g2370. PMID 24671956. S2CID 46535820.
Wise J (Juni 2014). "Open letter raises concerns about NICE guidance on statins". BMJ. 348 g3937. doi:10.1136/bmj.g3937. PMID 24920699. S2CID 42422361.
Gøtzsche PC (Juni 2014). "Muscular adverse effects are common with statins". BMJ. 348 g3724. doi:10.1136/bmj.g3724. PMID 24920687. S2CID 206902546.
Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (April 2014). "What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice". European Journal of Preventive Cardiology. 21 (4): 464–474. doi:10.1177/2047487314525531. PMID 24623264. S2CID 21064267.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, et al. (November 2013). "Statins and cognitive function: a systematic review". Annals of Internal Medicine. 159 (10): 688–697. doi:10.7326/0003-4819-159-10-201311190-00007. PMID 24247674. S2CID 207536770.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Smith DA (Mei 2014). "ACP Journal Club. Review: statins are not associated with cognitive impairment or dementia in cognitively intact adults". Annals of Internal Medicine. 160 (10): JC11, JC10. doi:10.7326/0003-4819-160-10-201405200-02011. PMID 24842433. S2CID 1990708.
O'Brien EC, Greiner MA, Xian Y, Fonarow GC, Olson DM, Schwamm LH, et al. (Oktober 2015). "Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study". Circulation. 132 (15): 1404–1413. doi:10.1161/CIRCULATIONAHA.115.016183. PMID 26246175. S2CID 11252336.
Yusuf S (September 2016). "Why do people not take life-saving medications? The case of statins". Lancet. 388 (10048): 943–945. doi:10.1016/s0140-6736(16)31532-x. PMID 27598664. S2CID 34832961.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Wood FA, Howard JP, Finegold JA, Nowbar AN, Thompson DM, Arnold AD, et al. (November 2020). "N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects". The New England Journal of Medicine. 383 (22): 2182–2184. doi:10.1056/NEJMc2031173. hdl:10044/1/84185. PMID 33196154. S2CID 226971988.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Colloca L, Barsky AJ (Februari 2020). "Placebo and Nocebo Effects". The New England Journal of Medicine. 382 (6): 554–561. doi:10.1056/NEJMra1907805. PMID 32023375. S2CID 211046068.
Nelson AJ, Puri R, Nissen SE (Juni 2020). "Statins in a Distorted Mirror of Media". Current Atherosclerosis Reports. 22 (8): 37. doi:10.1007/s11883-020-00853-9. PMID 32557172. S2CID 219730531.
Tan JT, Barry AR (Juni 2017). "Coenzyme Q10 supplementation in the management of statin-associated myalgia". American Journal of Health-System Pharmacy. 74 (11): 786–793. doi:10.2146/ajhp160714. PMID 28546301. S2CID 3825396.
Teichtahl AJ, Brady SR, Urquhart DM, Wluka AE, Wang Y, Shaw JE, et al. (Februari 2016). "Statins and tendinopathy: a systematic review". The Medical Journal of Australia. 204 (3): 115–21.e1. doi:10.5694/mja15.00806. PMID 26866552. S2CID 4652858.
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. (Februari 2010). "Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials". Lancet. 375 (9716): 735–742. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. S2CID 11544414.
He Y, Li X, Gasevic D, Brunt E, McLachlan F, Millenson M, et al. (Oktober 2018). "Statins and Multiple Noncardiovascular Outcomes: Umbrella Review of Meta-analyses of Observational Studies and Randomized Controlled Trials". Annals of Internal Medicine. 169 (8): 543–553. doi:10.7326/M18-0808. PMID 30304368. S2CID 52953760.
Carmena R, Betteridge DJ (April 2019). "Diabetogenic Action of Statins: Mechanisms". Current Atherosclerosis Reports. 21 (6): 23. doi:10.1007/s11883-019-0780-z. PMID 31037345. S2CID 140506916.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Alsheikh-Ali AA, Karas RH (Maret 2009). "The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials". Current Atherosclerosis Reports. 11 (2): 100–104. doi:10.1007/s11883-009-0016-8. PMID 19228482. S2CID 42869773.
Liu Y, Tang W, Wang J, Xie L, Li T, He Y, et al. (Februari 2014). "Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies". Cancer Causes & Control. 25 (2): 237–249. doi:10.1007/s10552-013-0326-6. PMID 24265089. S2CID 17931279.
Wu XD, Zeng K, Xue FQ, Chen JH, Chen YQ (Oktober 2013). "Statins are associated with reduced risk of gastric cancer: a meta-analysis". European Journal of Clinical Pharmacology. 69 (10): 1855–1860. doi:10.1007/s00228-013-1547-z. PMID 23748751. S2CID 16584300.
Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, et al. (Mei 2013). "Statins and primary liver cancer: a meta-analysis of observational studies". European Journal of Cancer Prevention. 22 (3): 229–234. doi:10.1097/cej.0b013e328358761a. PMID 23010949. S2CID 37195287.
Zhang Y, Zang T (2013). "Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005-2010". Urologia Internationalis. 90 (3): 259–262. doi:10.1159/000341977. PMID 23052323. S2CID 22078921.
Undela K, Srikanth V, Bansal D (Agustus 2012). "Statin use and risk of breast cancer: a meta-analysis of observational studies". Breast Cancer Research and Treatment. 135 (1): 261–269. doi:10.1007/s10549-012-2154-x. PMID 22806241. S2CID 35249884.
Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, et al. (Juli 2012). "Statin use and risk of pancreatic cancer: a meta-analysis". Cancer Causes & Control. 23 (7): 1099–1111. doi:10.1007/s10552-012-9979-9. PMID 22562222. S2CID 13171692.
Zhang XL, Geng J, Zhang XP, Peng B, Che JP, Yan Y, et al. (April 2013). "Statin use and risk of bladder cancer: a meta-analysis". Cancer Causes & Control. 24 (4): 769–776. doi:10.1007/s10552-013-0159-3. PMID 23361339. S2CID 9030195.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
An T, Hao J, Sun S, Li R, Yang M, Cheng G, et al. (Januari 2017). "Efficacy of statins for osteoporosis: a systematic review and meta-analysis". Osteoporosis International. 28 (1): 47–57. doi:10.1007/s00198-016-3844-8. PMID 27888285. S2CID 4723680.
Istvan ES, Deisenhofer J (Mei 2001). "Structural mechanism for statin inhibition of HMG-CoA reductase". Science. 292 (5519): 1160–1164. Bibcode:2001Sci...292.1160I. doi:10.1126/science.1059344. PMID 11349148. S2CID 37686043.
Cilla DD, Gibson DM, Whitfield LR, Sedman AJ (Juli 1996). "Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening". Journal of Clinical Pharmacology. 36 (7): 604–609. doi:10.1002/j.1552-4604.1996.tb04224.x. PMID 8844442. S2CID 13586550.
Laufs U, Custodis F, Böhm M (2006). "HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk". Drugs. 66 (2): 145–154. doi:10.2165/00003495-200666020-00002. PMID 16451090. S2CID 46985044.
Porter KE, Turner NA (Juli 2011). "Statins and myocardial remodelling: cell and molecular pathways". Expert Reviews in Molecular Medicine. 13 (e22): e22. doi:10.1017/S1462399411001931. PMID 21718586. S2CID 1975524.
Ferdinand KC (Februari 2011). "Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?". Current Atherosclerosis Reports. 13 (1): 64–72. doi:10.1007/s11883-010-0149-9. PMID 21104458. S2CID 32142669.
Vögeli B, Shima S, Erb TJ, Wagner T (Maret 2019). "Crystal structure of archaeal HMG-CoA reductase: insights into structural changes of the C-terminal helix of the class-I enzyme". FEBS Letters. 593 (5): 543–553. doi:10.1002/1873-3468.13331. PMID 30702149. S2CID 73412833.
Baldinelli L, Biselli R, Fattorossi A (Februari 2005). "Influence of ST 789 on murine thymocytes: a flow cytometry study of thymocyte subset distribution and of intracellular free Ca++ increase upon activation. Murine thymocytes and ST 789". Thymus. 19 (2 Suppl 1): S53–S61. doi:10.1111/j.1742-1241.2005.00461.x. PMID 1585420. S2CID 221814440.
Liu B, Yi Z, Guan X, Zeng YX, Ma F (Juli 2017). "The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis". Breast Cancer Research and Treatment. 164 (1): 1–11. doi:10.1007/s10549-017-4246-0. PMID 28432513. S2CID 3900946.
Batais MA, Khan AR, Bin Abdulhak AA (Agustus 2017). "The Use of Statins and Risk of Community-Acquired Pneumonia". Current Infectious Disease Reports. 19 (8): 26. doi:10.1007/s11908-017-0581-x. PMID 28639080. S2CID 20522253.

skepticalinquirer.org (Global: 7,734^th place; Indonesian: low place)

Hall H (2017). "Statin Denialism". Skeptical Inquirer. Vol. 41, no. 3. hlm. 40–43. Diarsipkan dari versi aslinya tanggal 6 Oktober 2018. Diakses tanggal 6 Oktober 2018.

tevapharm.com (Global: low place; Indonesian: low place)

"Teva Announces Final Approval of Lovastatin Tablets". Teva Pharmaceutical Industries Ltd. (Rilis pers). 31 Oktober 2019. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.

theguardian.com (Global: 16^th place; Indonesian: 31^st place)

Boseley S (8 September 2016). "Statins prevent 80,000 heart attacks and strokes a year in UK, study finds". The Guardian. Diarsipkan dari versi aslinya tanggal 8 Agustus 2017. Diakses tanggal 29 Desember 2017.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

thomasnet.com (Global: low place; Indonesian: low place)

news.thomasnet.com

Lane B (8 Mei 2012). "National Inventors Hall of Fame Honors 2012 Inductees". Diarsipkan dari asli tanggal 26 April 2019. Diakses tanggal 11 Mei 2014.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

"Cholesterol Drugs". American Heart Association. Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 24 Desember 2019.
National Clinical Guideline Centre (UK) (Juli 2014). Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. National Institute for Health and Clinical Excellence: Guidance. London: National Institute for Health and Care Excellence (UK). PMID 25340243. NICE Clinical Guidelines, No. 181. Diarsipkan dari versi aslinya tanggal 29 Mei 2020. Diakses tanggal 26 April 2020 – via National Library of Medicine.{{cite book}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"Should you be worried about severe muscle pain from statins?". Mayo Clinic. Diarsipkan dari versi aslinya tanggal 15 Mei 2024. Diakses tanggal 30 Oktober 2023.
Lane B (8 Mei 2012). "National Inventors Hall of Fame Honors 2012 Inductees". Diarsipkan dari asli tanggal 26 April 2019. Diakses tanggal 11 Mei 2014.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Landers P (9 Januari 2006). "How One Scientist Intrigued by Molds Found First Statin". The Wall Street Journal. Diarsipkan dari versi aslinya tanggal 29 Mei 2020. Diakses tanggal 11 Mei 2014.
Boseley S (8 September 2016). "Statins prevent 80,000 heart attacks and strokes a year in UK, study finds". The Guardian. Diarsipkan dari versi aslinya tanggal 8 Agustus 2017. Diakses tanggal 29 Desember 2017.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Husten L (24 Juli 2017). "Nissen Calls Statin Denialism A Deadly Internet-Driven Cult". CardioBrief. Diarsipkan dari versi aslinya tanggal 19 Desember 2017. Diakses tanggal 19 Desember 2017.
Hall H (2017). "Statin Denialism". Skeptical Inquirer. Vol. 41, no. 3. hlm. 40–43. Diarsipkan dari versi aslinya tanggal 6 Oktober 2018. Diakses tanggal 6 Oktober 2018.
"First-Time Generics – December 2001". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Juli 2009. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"First-Time Generics – April 2006". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Juli 2009. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"Pravastatin: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Februari 2023. Diakses tanggal 12 Februari 2023.
"First-Time Generics – June 2006". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 12 Juli 2009. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
DeNoon DJ (29 November 2011). "FAQ: Generic Lipitor". WebMD. Diarsipkan dari versi aslinya tanggal 5 Agustus 2020. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"First-Time Generic Drug Approvals – November 2011". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 8 Desember 2011. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"Atorvastatin: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diarsipkan dari versi aslinya tanggal 12 Februari 2023. Diakses tanggal 12 Februari 2023.
"First-Time Generic Drug Approvals – April 2012". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 19 Juli 2012. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"ANDA (Generic) Drug Approvals in 2016". U.S. Food and Drug Administration (FDA). 3 November 2018. Diarsipkan dari versi aslinya tanggal 11 Agustus 2020. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"FDA approves first generic Crestor". U.S. Food and Drug Administration (FDA) (Rilis pers). 29 April 2016. Diarsipkan dari asli tanggal 15 Maret 2020. Diakses tanggal 26 April 2020.{{cite press release}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"CDER 2017 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 November 2018. Diarsipkan dari asli tanggal 26 April 2020. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
National Collaborating Centre for Primary Care (2010). NICE clinical guideline 67: Lipid modification (PDF). London: National Institute for Health and Clinical Excellence. hlm. 38. Diarsipkan dari asli (PDF) tanggal 10 Oktober 2010.
"ACC/AHA ASCVD Risk Calculator". www.cvriskcalculator.com. Diarsipkan dari asli tanggal 9 Maret 2019. Diakses tanggal 8 Maret 2019.
"Cardiovascular disease: risk assessment and reduction, including lipid modification at www.nice.org.uk". 18 Juli 2014. Diarsipkan dari versi aslinya tanggal 12 Juni 2018. Diakses tanggal 1 Mei 2017.
National Institute for Health and Clinical Excellence (Maret 2010) [May 2008]. "Lipid modification – Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease – Quick reference guide" (PDF). Diarsipkan dari asli (PDF) tanggal 8 April 2011. Diakses tanggal 25 Agustus 2010.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
table adapted from the following source, but check individual references for technical explanations
- Consumer Reports, Drug Effectiveness Review Project (Maret 2013), "Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price" (PDF), Best Buy Drugs, Consumer Reports, hlm. 9, diarsipkan (PDF) dari versi aslinya tanggal 4 Februari 2017, diakses tanggal 27 Maret 2013
- "FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury". U.S. Food and Drug Administration (FDA). 1 Maret 2012. Diarsipkan dari versi aslinya tanggal 18 Maret 2013. Diakses tanggal 3 April 2013.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
- "FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs". U.S. Food and Drug Administration (FDA). 19 Januari 2016. Diarsipkan dari versi aslinya tanggal 13 Oktober 2019. Diakses tanggal 25 Maret 2018.
- Rull R, Henderson R (20 Januari 2015). "Rhabdomyolysis and Other Causes of Myoglobinuria". Diarsipkan dari asli tanggal 7 Mei 2015. Diakses tanggal 6 Mei 2015.
- Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (2019). "Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–e81. doi:10.1161/ATV.0000000000000073. ISSN 1079-5642. PMID 30580575. Diarsipkan dari versi aslinya tanggal 28 Mei 2024. Diakses tanggal 14 Mei 2024.
- Katherine Zeratsky, R.D., L.D., Mayo clinic: article on interference between grapefruit and medication Diarsipkan 29 October 2013 di Wayback Machine. Accessed 1 May 2017
- Reamy BV, Stephens MB (Juli 2007). "The grapefruit-drug interaction debate: role of statins". American Family Physician. 76 (2): 190, 192, author reply 192. PMID 17695563. Diarsipkan dari versi aslinya tanggal 10 November 2018. Diakses tanggal 29 April 2012.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
- "Statins and HIV or Hepatitis C Drugs: Drug Safety Communication – Interaction Increases Risk of Muscle Injury". U.S. Food and Drug Administration (FDA). 1 Maret 2012. Diarsipkan dari asli tanggal 18 Januari 2017. Diakses tanggal 12 Oktober 2019.
- "Questions Remain in Cholesterol Research". MedPageToday. 15 Agustus 2014. Diarsipkan dari versi aslinya tanggal 25 Februari 2021. Diakses tanggal 27 April 2015.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
- Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, et al. (Februari 1999). "Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver". Drug Metabolism and Disposition. 27 (2): 173–179. doi:10.1016/S0090-9556(24)15273-7. PMID 9929499. Diarsipkan dari asli tanggal 26 Agustus 2021. Diakses tanggal 8 November 2018.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
- "Triveram" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.
- "Triveram (2)" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 11 Agustus 2020. Diakses tanggal 7 Februari 2020.
- "Riclassificazione del medicinale per uso umano 'Triveram', ai sensi dell'articolo 8, comma 10, della legge 24 dicembre 1993, n. 537. (Determina n. DG/1422/2019). (19A06231)". GU Serie Generale n.238 (dalam bahasa Italia). 10 Oktober 2019. Diarsipkan dari versi aslinya tanggal 10 Agustus 2020. Diakses tanggal 7 Februari 2020.
- "Cholecomb" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 26 Agustus 2021. Diakses tanggal 7 Februari 2020.
- "Cholecomb (2)" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.
- "Rosumibe" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.
- "Rosumibe (2)" (PDF) (dalam bahasa Italia). Diarsipkan dari versi aslinya tanggal 12 Agustus 2020. Diakses tanggal 7 Februari 2020.
- Fang J (31 Oktober 2019). "Patent expires today on pharmaceutical superstar Lipitor". ZDNet. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.
- "Sandoz launches authorized fluvastatin generic in US". GaBI Online. 31 Oktober 2019. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.
- "Teva Announces Final Approval of Lovastatin Tablets". Teva Pharmaceutical Industries Ltd. (Rilis pers). 31 Oktober 2019. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.
- "FDA OKs Generic Version of Pravachol". WebMD. 25 April 2006. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
- "Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca". The New York Times. 21 Juli 2016. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.
- Wilson D (6 Maret 2011). "Drug Firms Face Billions in Losses as Patents End". The New York Times. Diarsipkan dari versi aslinya tanggal 22 November 2019. Diakses tanggal 31 Oktober 2019.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
- Berenson A (23 Juni 2006). "Merck Loses Protection for Patent on Zocor". The New York Times. Diarsipkan dari versi aslinya tanggal 14 Januari 2015. Diakses tanggal 31 Oktober 2019.

webmd.com (Global: 2,056^th place; Indonesian: 872^nd place)

DeNoon DJ (29 November 2011). "FAQ: Generic Lipitor". WebMD. Diarsipkan dari versi aslinya tanggal 5 Agustus 2020. Diakses tanggal 26 April 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"FDA OKs Generic Version of Pravachol". WebMD. 25 April 2006. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

worldcat.org (Global: 4^th place; Indonesian: 5^th place)

search.worldcat.org

Ko HH, Lareu RR, Dix BR, Hughes JD (24 Oktober 2017). "Statins: antimicrobial resistance breakers or makers?". PeerJ. 5 e3952. doi:10.7717/peerj.3952. ISSN 2167-8359. PMC 5659212. PMID 29085751.
Gesto DS, Pereira CM, Cerqueira NM, Sousa SF (26 Agustus 2020). "An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia". Molecules. 25 (17): 3891. doi:10.3390/molecules25173891. ISSN 1420-3049. PMC 7503714. PMID 32859023.
Tunnicliffe DJ, Palmer SC, Cashmore BA, Saglimbene VM, Krishnasamy R, Lambert K, et al. (29 November 2023). "HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis". The Cochrane Database of Systematic Reviews. 11 (11) CD007784. doi:10.1002/14651858.CD007784.pub3. ISSN 1469-493X. PMC 10685396. PMID 38018702.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Sheng X, Murphy MJ, MacDonald TM, Wei L (30 Agustus 2012). "The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population". BMC Public Health. 12 (1): 712. doi:10.1186/1471-2458-12-712. ISSN 1471-2458. PMC 3490740. PMID 22935195.
Zhang X, Xing L, Jia X, Pang X, Xiang Q, Zhao X, et al. (27 April 2020). "Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials". Cardiovascular Therapeutics. 2020 e3987065. doi:10.1155/2020/3987065. ISSN 1755-5914. PMC 7201823. PMID 32411300.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (2019). "Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–e81. doi:10.1161/ATV.0000000000000073. ISSN 1079-5642. PMID 30580575. Diarsipkan dari versi aslinya tanggal 28 Mei 2024. Diakses tanggal 14 Mei 2024.
Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM (19 Januari 2012). "Generic Atorvastatin and Health Care Costs". New England Journal of Medicine. 366 (3): 201–204. doi:10.1056/NEJMp1113112. ISSN 0028-4793. PMC 3319770. PMID 22149736.
Gutlapalli SD, Farhat H, Irfan H, Muthiah K, Pallipamu N, Taheri S, et al. (2022). "The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022". Cureus. 14 (12) e32323. doi:10.7759/cureus.32323. ISSN 2168-8184. PMC 9825119. PMID 36628002.
Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, et al. (1 November 2024). "Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study". Heart (dalam bahasa Inggris). 110 (21): 1277–1285. doi:10.1136/heartjnl-2024-324052. ISSN 1355-6037. PMC 11503164. PMID 39256053.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

wsj.com (Global: 94^th place; Indonesian: 146^th place)

Landers P (9 Januari 2006). "How One Scientist Intrigued by Molds Found First Statin". The Wall Street Journal. Diarsipkan dari versi aslinya tanggal 29 Mei 2020. Diakses tanggal 11 Mei 2014.

zdnet.com (Global: 1,235^th place; Indonesian: 844^th place)

Fang J (31 Oktober 2019). "Patent expires today on pharmaceutical superstar Lipitor". ZDNet. Diarsipkan dari versi aslinya tanggal 31 Oktober 2019. Diakses tanggal 31 Oktober 2019.

Statin (Indonesian Wikipedia)

aafp.org (Global: 2,559th place; Indonesian: 1,695th place)

acc.org (Global: low place; Indonesian: low place)

adsabs.harvard.edu (Global: 14th place; Indonesian: 19th place)

ui.adsabs.harvard.edu

agenziafarmaco.gov.it (Global: low place; Indonesian: low place)

farmaci.agenziafarmaco.gov.it

ahajournals.org (Global: 4,716th place; Indonesian: 3,949th place)

archive-it.org (Global: 1,292nd place; Indonesian: 892nd place)

wayback.archive-it.org

archive.org (Global: 6th place; Indonesian: 3rd place)

aspetjournals.org (Global: 8,671st place; Indonesian: 7,247th place)

dmd.aspetjournals.org

cardiobrief.org (Global: low place; Indonesian: low place)

cnn.com (Global: 36th place; Indonesian: 61st place)

money.cnn.com

consumerreports.org (Global: 6,864th place; Indonesian: 5,636th place)

cvriskcalculator.com (Global: low place; Indonesian: low place)

doi.org (Global: 2nd place; Indonesian: 2nd place)

fda.gov (Global: 470th place; Indonesian: 343rd place)

fda.gov

accessdata.fda.gov

gabionline.net (Global: low place; Indonesian: low place)

gazzettaufficiale.it (Global: 2,811th place; Indonesian: low place)

hdl.handle.net (Global: 66th place; Indonesian: 122nd place)

heart.org (Global: low place; Indonesian: 7,540th place)

watchlearnlive.heart.org

mayoclinic.com (Global: 6,290th place; Indonesian: 4,130th place)

mayoclinic.org (Global: 2,191st place; Indonesian: 1,118th place)

medpagetoday.com (Global: low place; Indonesian: low place)

nice.org.uk (Global: 4,081st place; Indonesian: 3,142nd place)

nih.gov (Global: 5th place; Indonesian: 6th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nihr.ac.uk (Global: low place; Indonesian: low place)

evidence.nihr.ac.uk

nytimes.com (Global: 7th place; Indonesian: 20th place)

patient.co.uk (Global: low place; Indonesian: low place)

semanticscholar.org (Global: 15th place; Indonesian: 26th place)

api.semanticscholar.org

skepticalinquirer.org (Global: 7,734th place; Indonesian: low place)

tevapharm.com (Global: low place; Indonesian: low place)

theguardian.com (Global: 16th place; Indonesian: 31st place)

thomasnet.com (Global: low place; Indonesian: low place)

news.thomasnet.com

web.archive.org (Global: 1st place; Indonesian: 1st place)

webmd.com (Global: 2,056th place; Indonesian: 872nd place)

worldcat.org (Global: 4th place; Indonesian: 5th place)

search.worldcat.org

wsj.com (Global: 94th place; Indonesian: 146th place)

zdnet.com (Global: 1,235th place; Indonesian: 844th place)

aafp.org (Global: 2,559^th place; Indonesian: 1,695^th place)

adsabs.harvard.edu (Global: 14^th place; Indonesian: 19^th place)

ahajournals.org (Global: 4,716^th place; Indonesian: 3,949^th place)

archive-it.org (Global: 1,292^nd place; Indonesian: 892^nd place)

archive.org (Global: 6^th place; Indonesian: 3^rd place)

aspetjournals.org (Global: 8,671^st place; Indonesian: 7,247^th place)

cnn.com (Global: 36^th place; Indonesian: 61^st place)

consumerreports.org (Global: 6,864^th place; Indonesian: 5,636^th place)

doi.org (Global: 2^nd place; Indonesian: 2^nd place)

fda.gov (Global: 470^th place; Indonesian: 343^rd place)

gazzettaufficiale.it (Global: 2,811^th place; Indonesian: low place)

hdl.handle.net (Global: 66^th place; Indonesian: 122^nd place)

heart.org (Global: low place; Indonesian: 7,540^th place)

mayoclinic.com (Global: 6,290^th place; Indonesian: 4,130^th place)

mayoclinic.org (Global: 2,191^st place; Indonesian: 1,118^th place)

nice.org.uk (Global: 4,081^st place; Indonesian: 3,142^nd place)

nih.gov (Global: 5^th place; Indonesian: 6^th place)

nytimes.com (Global: 7^th place; Indonesian: 20^th place)

semanticscholar.org (Global: 15^th place; Indonesian: 26^th place)

skepticalinquirer.org (Global: 7,734^th place; Indonesian: low place)

theguardian.com (Global: 16^th place; Indonesian: 31^st place)

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

webmd.com (Global: 2,056^th place; Indonesian: 872^nd place)

worldcat.org (Global: 4^th place; Indonesian: 5^th place)

wsj.com (Global: 94^th place; Indonesian: 146^th place)

zdnet.com (Global: 1,235^th place; Indonesian: 844^th place)